Prosthetic valve and delivery tool therefor

Information

  • Patent Grant
  • 11382746
  • Patent Number
    11,382,746
  • Date Filed
    Wednesday, December 12, 2018
    6 years ago
  • Date Issued
    Tuesday, July 12, 2022
    2 years ago
Abstract
Embodiments of the present disclosure include apparatus for use at a native valve of a heart of a subject. A delivery tool has a shaft, a capsule disposed at a distal portion of the tool, and a balloon that is disposed within the capsule and coupled to the shaft. A tubular frame of a prosthetic valve is compressed around the balloon, such that shape-memory flanges of the prosthetic valve, and a shape-memory upstream support portion of the prosthetic valve, are each constrained within a respective capsule-portion of the capsule. The capsule is openable by moving the capsule-portions apart, such that the flanges and the upstream support portion automatically deflect radially outward, while the tubular frame remains compressed around the balloon, and inflation of the balloon plastically expands the tubular frame radially. Other embodiments are also described.
Description
CROSS-REFERENCES TO RELATED APPLICATIONS

The present application is the US National Phase of PCT application IL2018/051350 to Hariton et al., filed Dec. 12, 2018, and entitled “PROSTHETIC VALVE AND DELIVERY TOOL THEREFOR,” which published as WO/2019/116369, and which claims priority from UK patent application GB 1720803.4, filed Dec. 13, 2017, and entitled “PROSTHETIC VALVE AND DELIVERY TOOL THEREFOR,” which is incorporated herein by reference.


FIELD OF THE INVENTION

Some applications of the present invention relate in general to percutaneous delivery of medical implants. More specifically, some applications of the present invention relate to prosthetic cardiac valves and techniques for implantation thereof.


BACKGROUND

Dilation of the annulus of a heart valve, such as that caused by ischemic heart disease, prevents the valve leaflets from fully coapting when the valve is closed. Regurgitation of blood from the ventricle into the atrium results in increased total stroke volume and decreased cardiac output, and ultimate weakening of the ventricle secondary to a volume overload and a pressure overload of the atrium.


SUMMARY OF THE INVENTION

An implant is provided having self-expanding portions, and non-self-expanding portions. The implant comprises a non-self-expanding tubular frame, which is balloon-expandable. The implant further comprises an outer frame, which comprises self-expanding flanges and a self-expanding upstream support portion. The self-expanding nature of the flanges and upstream support portion is provided by the outer frame being composed of a shape-memory alloy. The tubular frame is composed of a different material.


The outer frame is coupled to the tubular frame via pins that are composed of the same material as the tubular frame. One end of each pin is secured to the outer frame by a head of the pin. The other end of each pin is secured to the tubular frame by welding.


A delivery tool comprises a capsule that has two capsule-portions, one to constrain the flanges, and one to constrain the upstream support portion. The delivery tool further comprises a balloon, disposed within the tubular frame. At the implantation site, the flanges and upstream support portion are released from the capsule, and automatically deflect radially outwards. Subsequently, the balloon is inflated to radially expand the tubular frame.


The delivery tool further comprises projections, which are sufficiently rigid to axially push the tubular frame in order to press the flanges against tissue at the implantation site, but which are sufficiently flexible to not inhibit inflation of the balloon.


There is therefore provided, in accordance with an application of the present invention, apparatus for use at a native valve of a heart of a subject, the apparatus including:


a delivery tool, including:

    • a shaft, having a shaft-axis;
    • a capsule, disposed at a distal portion of the tool, and including an upstream capsule-portion and a downstream capsule-portion, the capsule being openable by moving the upstream capsule-portion and the downstream capsule-portion apart; and
    • a balloon, coupled to the shaft, and disposed within the capsule; and a prosthetic valve, including:
    • a tubular frame, compressed around the balloon, and disposed within the capsule;
    • one or more shape-memory flanges, constrained within the downstream capsule-portion; and
    • a shape-memory upstream support portion, constrained within the upstream capsule-portion,


      and:


the flanges are configured to automatically deflect radially outward upon exposure from the downstream capsule-portion,


the upstream support portion is configured to automatically deflect radially outward upon exposure from the upstream capsule-portion,


the tubular frame is configured to remain compressed around the balloon upon exposure of the tubular frame from the capsule, and


while the tubular frame is exposed from the capsule, inflation of the balloon plastically expands the tubular frame radially.


In an application, the prosthetic valve further includes one or more prosthetic valve leaflets disposed within the lumen and coupled to the tubular frame.


In an application, the tubular frame is disposed within the downstream capsule-portion of the capsule.


In an application, the tubular frame is composed of a material that is not a shape-memory alloy.


In an application, the tubular frame is composed of steel.


In an application, the tubular frame is composed of cobalt chrome.


In an application, the flanges are composed of a shape-memory alloy.


In an application, the flanges are composed of nickel titanium.


In an application, the balloon is fixed to the shaft.


In an application, both the upstream capsule-portion and the downstream capsule-portion are axially movable with respect to the shaft.


In an application:


a first capsule-portion selected from the group consisting of: the upstream capsule-portion and the downstream capsule-portion is attached to a tube, and is axially movable with respect to the shaft by the tube being slid over the shaft, and


a second capsule-portion selected from the group is attached to a rod, and is axially movable with respect to the shaft by the rod being slid though the shaft.


In an application, the upstream capsule-portion is retractable from over the upstream support portion by being moved away from the balloon, and the downstream capsule-portion is retractable from over the flanges by being moved away from the balloon.


In an application, the delivery tool further includes one or more elongate projections disposed within the downstream capsule-portion, each of the projections having (i) a tip-portion, and (ii) a base-portion, disposed deeper than the tip-portion into the downstream capsule-portion, the projections arranged circumferentially around the shaft-axis such that the tip-portions are arranged circumferentially around a downstream balloon-portion of the balloon, with the tip-portion of each projection being closer than its corresponding base-portion to the tubular frame.


In an application, each of the projections is sufficiently stiff that, when pushed against the tubular frame, it is capable of applying, to the tubular frame, an axial pushing force of at least 0.5 N.


In an application, each of the projections is sufficiently stiff that, when pushed against the tubular frame, the one or more projections are capable collectively of applying, to the tubular frame, an axial pushing force of at least 3 N.


In an application, when pushed against the tubular frame, the one or more projections are capable collectively of applying, to the tubular frame, an axial pushing force of at least 3 N and no more than 100 N.


In an application, when pushed against the tubular frame, the one or more projections are capable collectively of applying, to the tubular frame, an axial pushing force of at least 3 N and no more than 30 N.


In an application, when pushed against the tubular frame, the one or more projections are capable collectively of applying, to the tubular frame, an axial pushing force of at least 6 N and no more than 30 N.


In an application, when pushed against the tubular frame, the one or more projections are capable collectively of applying, to the tubular frame, an axial pushing force of at least 40 N and no more than 100 N.


In an application, when pushed against the tubular frame, the one or more projections are capable collectively of applying, to the tubular frame, an axial pushing force of at least 40 N and no more than 80 N.


In an application, when pushed against the tubular frame, the one or more projections are capable collectively of applying, to the tubular frame, an axial pushing force of at least 60 N and no more than 100 N.


In an application, the tubular frame is disposed within the downstream capsule-portion of the capsule, and the downstream capsule-portion is retractable from over the tubular frame and at least the tip-portions, exposing, from the downstream capsule-portion, the tubular frame and at least the tip-portions.


In an application, while the tubular frame and the tip-portions are exposed from the downstream capsule-portion, inflation of the balloon (i) radially expands the tubular frame, and (ii) deflects each of the projections radially outward within a respective radial plane on which the shaft-axis and the projection lie.


In an application, while the tubular frame and the tip-portions are exposed from the downstream capsule-portion, inflation of the balloon uniformly fills the lumen of the tubular frame.


In an application, a widest part of the balloon is disposed within the lumen.


In an application, each projection has a radial stiffness in its radial plane, and has a lateral stiffness in a respective lateral plane, the lateral stiffness being greater than the radial stiffness.


In an application:


the balloon has an upstream balloon-portion, a downstream balloon-portion, and a body balloon-portion therebetween,


the tubular frame is compressed around the body balloon-portion, and


while the tubular frame and the tip-portions are exposed from the downstream capsule-portion, inflation of the balloon (i) radially expands the tubular frame by pressing the body balloon-portion radially outward against the tubular frame, and (ii) deflects the projections radially outward by pressing the downstream balloon-portion radially outward against the projections.


In an application, the downstream balloon-portion of the balloon extends away from the tubular frame, and is tapered.


In an application, the upstream balloon-portion of the balloon extends away from the tubular frame, and is tapered.


In an application, the tip-portion of each of the projections abuts the tubular frame, and the apparatus is configured such that the tip-portion of each of the projections remains in contact with the tubular frame as the balloon is inflated.


In an application, a downstream end of the tubular frame defines a frame-circumference, the tip-portions define a projection-circumference, and while the tubular frame and the tip-portions are exposed from the downstream capsule-portion, inflation of the balloon increases the projection-circumference at the same rate as the balloon increases the frame-circumference.


In an application, the tip-portion of each of the projections abuts the tubular frame.


In an application, the projections are not attached to the tubular frame.


There is further provided, in accordance with an application of the present invention, apparatus for delivery of a prosthetic heart valve to an annulus of a native heart valve, the apparatus including:


a shaft, having a longitudinal shaft-axis;


an inflatable balloon, disposed at a distal end of the shaft; and


one or more projections extending distally from the shaft, such that the projections are arranged around a proximal portion of the balloon,


and:


inflation of the balloon causes radial expansion of the balloon, the radial expansion of the balloon applying a radial force to each of the projections, and


each of the projections is sufficiently radially flexible that the radial force deflects the projections radially outward.


In an application, for each of the projections:


the projection defines:

    • a respective radial plane on which the shaft-axis and the projection lie, and within which the projection deflects in response to the radial force, and
    • a lateral plane, tangential to the circumference, and on which the projection lies,


the projection has a radial stiffness, in its radial plane, and


the projection has a lateral stiffness, in its lateral plane, that is greater than the radial stiffness.


In an application, the apparatus further includes a tubular frame at the distal end of the shaft, the tubular frame defining a longitudinal lumen, and the balloon is disposed within the lumen.


In an application, each of the projections is sufficiently stiff that it is capable of applying, to the tubular frame, an axial pushing force of at least 0.5 N.


In an application, each of the projections is sufficiently stiff that the one or more projections are capable collectively of applying, to the tubular frame, an axial pushing force of at least 3 N.


In an application, the apparatus further includes one or more prosthetic valve leaflets disposed within the lumen and coupled to the tubular frame.


In an application, the balloon:


has a longitudinal balloon-axis, collinear with the longitudinal shaft-axis, the balloon-axis extending through the lumen,


has (i) a deflated state, and (ii) an inflated state in which the balloon has a widest part, and


is positioned with respect to the tubular frame such that the widest part is within the lumen.


In an application, the balloon, in its inflated state, uniformly fills the lumen.


In an application, in the inflated state of the balloon, the proximal portion of the balloon tapers proximally away from the tubular frame.


In an application, the balloon, in its inflated state, has a tapered distal portion that tapers distally away from the tubular frame.


In an application, the widest part of the balloon is disposed longitudinally between the proximal portion and the distal portion.


In an application, each of the projections has a tip-portion that abuts a proximal surface of the tubular frame.


In an application, the tip-portion of each of the projections is not attached to the tubular frame.


In an application, inflation of the balloon simultaneously increases (i) a radial distance between the tip-portion of one of the projections and the tip-portion of an opposite one of the projections, and (ii) a circumference of the tubular frame.


There is further provided, in accordance with an application of the present invention, apparatus for use in a heart of a subject, the apparatus including:


a tubular frame that circumscribes a longitudinal axis to define a lumen along the longitudinal axis;


a valve member, disposed within the lumen and coupled to the tubular frame;


an outer frame:

    • disposed radially outward from the tubular frame,
    • including a flange, and
    • defining an eyelet; and


a pin:

    • defining a shaft and a head, and
    • coupling the outer frame to the tubular frame,


      and:


the outer frame is composed of a shape-memory alloy,


the tubular frame and the pin are composed of a material that is not the shape-memory alloy,


the head is disposed against the outer frame, radially outward from the eyelet,


the shaft extends from the head through the eyelet to the tubular frame, and


the shaft is welded to the tubular frame.


In an application, the outer frame further includes an upstream support portion, shape-set to extend radially outward from the tubular frame.


In an application, the flange is shape-set to extend radially outward from the tubular frame.


In an application, the outer frame further includes an upstream support portion, upstream support portion is shape-set to extend radially outward from the tubular frame, and the flange is shape-set to extend radially outward from the tubular frame and toward the upstream support portion.


In an application:


the flange has a root-portion and a tip, and extends away from the tubular frame from the root-portion to the tip,


the eyelet is defined at the root-portion of the flange, and


the head is disposed against the root-portion of the flange, radially outward from the eyelet.


In an application, the eyelet is an outer eyelet, and the tubular frame defines an inner eyelet, the shaft extending through the inner eyelet.


In an application, the shape-memory alloy is nickel titanium.


In an application, the material is not a shape-memory material.


In an application, the material is steel.


In an application, the material is cobalt chrome.


In an application, the flange is one of a plurality of flanges, and the outer frame includes the plurality of flanges, and circumscribes the tubular frame.


In an application, the eyelet is one of a plurality of eyelets, and the outer frame defines the plurality of eyelets.


In an application, the flanges of the plurality of flanges are equal in number to the eyelets of the plurality of eyelets.


In an application, the eyelet is one of a plurality of eyelets, and the root-portion of each flange of the plurality of flanges defines a respective eyelet of the plurality of eyelets.


There is further provided, in accordance with an application of the present invention, a method for constructing a prosthetic heart valve, the method including:


from a tube of a shape-memory alloy, cutting an outer frame that includes a flange and defines an eyelet;


from a tube of a material that is not the shape-memory alloy, cutting a tubular frame that circumscribes a longitudinally axis to define a lumen along the longitudinal axis;


positioning the outer frame against the tubular frame, radially-outward from the tubular frame;


passing a shaft of a pin through the eyelet such that (i) the shaft of the eyelet extends to the tubular frame, and (ii) a head of the pin is disposed against the outer frame radially outward from the eyelet, the pin being composed of the material;


welding the shaft to the tubular frame;


lining at least part of the lumen with a lining; and


securing a plurality of prosthetic leaflets within the lumen.


In an application, the method further includes shape-setting the flange to extend radially outward.


In an application:


cutting the outer frame includes cutting the outer frame such that the flange has a root-portion and a tip, and defines the eyelet at the root-portion, and


passing the shaft of the pin through the eyelet such that the head of the pin is disposed against the outer frame radially outward from the eyelet, includes passing the shaft of the pin through the eyelet such that the head of the pin is disposed against the root-portion of the flange, radially outward from the eyelet.


In an application:


the eyelet is an outer eyelet, and cutting the tubular frame includes cutting the tubular frame such that the tubular frame defines an inner eyelet, and


the step of passing the shaft includes passing the shaft through the outer eyelet and through the inner eyelet, and


welding the shaft to the tubular frame includes welding the shaft to the tubular frame at the inner eyelet.


In an application, the shape-memory alloy is nickel titanium, and cutting the outer frame from the tube of the shape-memory alloy includes cutting the outer frame from a tube of nickel titanium.


In an application, the material is not a shape-memory material, and cutting the tubular frame includes cutting the tubular frame from the material that is not a shape-memory material.


In an application, the material is steel, and cutting the tubular frame from the tube of the material includes cutting the tubular frame from a tube of steel.


In an application, the material is cobalt chrome, and cutting the tubular frame from the tube of the material includes cutting the tubular frame from a tube of cobalt chrome.


In an application, cutting the outer frame includes cutting the outer frame that further includes an upstream support portion.


In an application, the method further includes shape-setting the upstream support portion to extend radially outward.


In an application:


the flange is one of a plurality of flanges,


cutting the outer frame includes cutting the outer frame such that the outer frame defines the plurality of flanges, and


positioning the outer frame includes positioning the outer frame such that the outer frame circumscribes the tubular frame.


In an application, the eyelet is one of a plurality of eyelets, and cutting the outer frame includes cutting the outer frame such that the outer frame defines the plurality of eyelets.


In an application, cutting the outer frame includes cutting the outer frame such that the outer frame has an equal number of flanges and eyelets.


There is further provided, in accordance with an application of the present invention, a method for use at a native valve of a heart of a subject, the method including:


advancing, to the heart, an implant that includes a tubular frame, the tubular frame disposed on a distal portion of a tool, the distal portion of the tool including:

    • a distal end of a shaft,
    • an inflatable balloon, having a body portion that is disposed within the tubular frame,
    • one or more projections extending, from the shaft, distally over at least a proximal portion of the balloon toward the tubular frame, the proximal portion of the balloon being proximal from the body balloon-portion of the balloon;


pushing the projections distally against the tubular frame to apply a distal pushing force to the tubular frame; and


while maintaining contact between the projections and the tubular frame, inflating the balloon such that:

    • radial expansion of the body balloon-portion radially expands the tubular frame, and
    • radial expansion of the proximal portion deflects the projections radially outward.


In an application, pushing the projections distally against the tubular frame comprises pushing the projections distally against the tubular frame such that the projections collectively apply a distal pushing force of at least 3 N to the tubular frame.


In an application, pushing the projections distally against the tubular frame comprises pushing the projections distally against the tubular frame such that the projections collectively apply a distal pushing force of at least 3 N and no more than 100 N.


In an application, pushing the projections distally against the tubular frame comprises pushing the projections distally against the tubular frame such that the projections collectively apply a distal pushing force of at least 3 N and no more than 30 N.


In an application, pushing the projections distally against the tubular frame comprises pushing the projections distally against the tubular frame such that the projections collectively apply a distal pushing force of at least 6 N and no more than 30 N.


In an application, pushing the projections distally against the tubular frame comprises pushing the projections distally against the tubular frame such that the projections collectively apply a distal pushing force of at least 40 N and no more than 100 N.


In an application, pushing the projections distally against the tubular frame comprises pushing the projections distally against the tubular frame such that the projections collectively apply a distal pushing force of at least 40 N and no more than 80 N.


In an application, pushing the projections distally against the tubular frame comprises pushing the projections distally against the tubular frame such that the projections collectively apply a distal pushing force of at least 60 N and no more than 100 N.


In an application:


the implant includes one or more self-expanding flanges,


the tool distal portion of the tool includes a capsule;


advancing the implant includes advancing the tubular frame while at least the flanges are disposed within, and constrained by, the capsule,


the method further includes, prior to pushing the projections distally, allowing the flanges to self-expand by exposing the flanges from the capsule, and


the step of pushing the projections distally against the tubular frame includes pushing the implant distally such that the flanges press against tissue of the native valve.


In an application, advancing the implant includes advancing the implant while the projections are disposed within the capsule, and exposing the flanges from the capsule includes retracting the capsule proximally with respect to the implant such that the flanges and the projections become exposed from the capsule.


There is further provided, in accordance with an application of the present invention, a method for use at a native valve of a heart of a subject, the method including:


advancing, to the heart:

    • a distal portion of a delivery tool, the delivery tool including:
      • a shaft that extends to the distal portion of the delivery tool,
      • a capsule disposed at the distal portion of the delivery tool, and including an upstream capsule-portion and a downstream capsule-portion, and
      • a balloon, coupled to the shaft, and disposed at least partly within the capsule, and
    • an implant disposed within the capsule, and including a tubular frame and one or more shape-memory flanges, the tubular frame compressed around the balloon, and the flanges constrained within the downstream capsule-portion;


exposing the flanges from the downstream capsule-portion such that the flanges automatically deflect radially outward;


subsequently, pressing the flanges against a downstream surface of the native valve by moving the implant in an upstream direction; and


while the flanges are in contact with the downstream surface, plastically expanding the tubular frame radially by inflating the balloon.


In an application, plastically expanding the tubular frame includes plastically expanding the tubular frame by radially by inflating the balloon while continuing to press the flanges against the downstream surface.


In an application, exposing the flanges from the downstream capsule-portion includes moving the downstream capsule-portion away from the upstream capsule-portion.


In an application, advancing the implant includes advancing the implant while the tubular frame is disposed within the downstream capsule-portion, and the method further includes exposing the tubular frame from the downstream capsule-portion.


In an application, exposing the tubular frame from the downstream capsule-portion includes exposing the tubular frame from the downstream capsule-portion prior to the step of pressing the flanges.


In an application, exposing the tubular frame from the downstream capsule-portion includes exposing the tubular frame entirely from the downstream capsule-portion without causing the tubular frame to expand.


In an application, the implant further includes a shape-memory upstream support portion, constrained within the upstream capsule-portion, and the method further includes, prior to expanding the tubular frame, exposing the upstream support portion from the upstream capsule-portion such that the upstream support portion automatically deflects radially outward.


In an application, moving the implant in the upstream direction includes moving the implant such that the upstream support portion, constrained within the upstream capsule portion, is disposed upstream of the native valve, and exposing the upstream support portion includes exposing the upstream support portion such that the upstream support portion automatically deflects radially outwards and contacts an upstream surface of the native valve.


In an application:


the implant is compressed around a body balloon-portion of the balloon,


the tool further includes one or more projections, each of the projections having a base-portion and a tip-portion,


the projections extend, from the shaft, over at least a downstream balloon-portion of the balloon toward the tubular frame, such that the tip-portion of each of the projections is closer than its corresponding base-portion to the tubular frame, and


pressing the flanges against the downstream surface by moving the implant in the upstream direction includes pushing the implant in the upstream direction by pushing the tip-portions against the tubular frame.


In an application, expanding the tubular frame includes inflating the balloon such that (i) the body balloon-portion radially expands the tubular frame by pressing radially outward against the tubular frame, and (ii) the downstream balloon-portion deflects the projections radially outward by pressing radially outward against the projections.


In an application, advancing the distal portion of the delivery tool includes advancing the distal portion of the delivery tool while the projections are disposed within the downstream capsule-portion, and the method further includes, prior to radially expanding the tubular frame, exposing at least the tips of the projections from the downstream capsule-portion.


In an application, exposing at least the tips of the projections from the downstream capsule-portion includes exposing at least the tips of the projections from the downstream capsule-portion prior to pressing the flanges against the downstream surface of the native valve.


There is further provided, in accordance with an application of the present invention, a method for use at a native valve of a heart of a subject, the method including:


advancing, to the heart:

    • a distal portion of a delivery tool, the delivery tool including:
      • a shaft that extends to the distal portion of the delivery tool,
      • a capsule disposed at the distal portion of the delivery tool, and
      • a balloon, coupled to the shaft, and
    • an implant disposed within the capsule, and including a tubular frame and an array of shape-memory flanges arranged around an outside of the tubular frame, the tubular frame compressed around the balloon, and the flanges constrained within the capsule;


subsequently, exposing the flanges from the capsule such that the flanges automatically deflect radially outward away from the tubular frame, and such that the array defines an inter-flange distance;


subsequently, by partially inflating the balloon to a partially-inflated state:

    • (i) partially radially expanding the tubular frame, and (ii) partially increasing the inter-flange distance;


while the balloon remains in the partially-inflated state, pressing the flanges against a downstream surface of the native valve by moving the implant in an upstream direction; and


subsequently, by further inflating the balloon to a further-inflated state, further radially expanding the tubular frame.


In an application, inflating the balloon to a further-inflated state further includes increasing the inter-flange distance.


In an application:


exposing the flanges includes exposing the flanges while the flanges are positioned upstream of the native valve; and


the method further includes, prior to pressing the flanges against the downstream surface of the native valve, moving the exposed flanges to be downstream of the native valve.


In an application, partially inflating the balloon includes partially inflating the balloon while the flanges are positioned upstream of the native valve.


In an application, inflating the balloon to the further-inflated state includes inflating the balloon to the further-inflated state while continuing to press the flanges against the downstream surface.


In an application, exposing the flanges from the capsule includes moving a downstream capsule-portion of the capsule away from an upstream capsule-portion of the capsule.


In an application, advancing the implant includes advancing the implant while the tubular frame is disposed within the downstream capsule-portion, and the method further includes exposing the tubular frame from the downstream capsule-portion.


In an application, exposing the tubular frame from the downstream capsule-portion includes exposing the tubular frame from the downstream capsule-portion prior to pressing the flanges against the downstream surface of the native valve.


In an application, exposing the tubular frame from the downstream capsule-portion includes exposing the tubular frame entirely from the downstream capsule-portion without causing the tubular frame to expand.


In an application, the implant further includes a shape-memory upstream support portion, constrained within the capsule, and the method further includes, subsequent to pressing the flanges against a downstream surface of the native valve, exposing the upstream support portion from the capsule such that the upstream support portion automatically deflects radially outward.


In an application, exposing the upstream support portion includes exposing the upstream support portion such that the upstream support portion contacts an upstream surface of the native valve.


In an application:


advancing the implant disposed within the capsule, the tubular frame compressed around the balloon, includes advancing the implant disposed within the capsule, the tubular frame compressed around a body balloon-portion of the balloon;


the distal portion of the delivery tool includes one or more projections, each of the projections having a base-portion and a tip-portion;


advancing the distal portion of the delivery tool includes advancing the distal portion of the delivery tool while the one or more projections extend, from the shaft, over at least a downstream balloon-portion of the balloon toward the tubular frame, such that the tip-portion of each of the projections is closer than its corresponding base-portion to the tubular frame; and


pressing the flanges against the downstream surface by moving the implant in the upstream direction includes pushing the implant in the upstream direction by pushing the tip-portions against the tubular frame.


In an application, inflating the balloon includes inflating the balloon such that (i) the body balloon-portion radially expands the tubular frame by pressing radially outward against the tubular frame, and (ii) the downstream balloon-portion deflects the projections radially outward by pressing radially outward against the projections.


In an application, advancing the distal portion of the delivery tool includes advancing the distal portion of the delivery tool while the projections are disposed within the capsule, and the method further includes, prior to partially radially expanding the tubular frame, exposing at least the tip-portions of the projections from the capsule.


There is further provided, in accordance with an application of the present invention, an apparatus for delivery of a prosthetic heart valve to an annulus of a native heart valve, the apparatus including:


a shaft, having a longitudinal shaft-axis;


a capsule, disposed at a distal portion of the shaft;


a balloon, coupled to the shaft, and disposed within the capsule;


one or more projections extending distally from the shaft, such that the projections are arranged around a proximal portion of the balloon; and


a prosthetic valve, including a tubular frame, compressed around the balloon, and disposed within the capsule;


and:


the tubular frame is configured to remain compressed around the balloon upon exposure of the tubular frame from the capsule, such that:

    • inflation of the balloon to a partially-inflated state partially radially expands the tubular frame, and
    • inflation of the balloon to a further-inflated state further radially expands the tubular frame;


inflation of the balloon applies a radial force to each of the projections; and


each of the projections is:

    • sufficiently radially flexible that the radial force deflects the projections radially outward,
    • sufficiently rigid to axially push the tubular frame while:
      • the balloon is in the partially-inflated state within the tubular frame, and
      • the projections are radially outwardly deflected by the balloon in the partially-inflated state.


The present invention will be more fully understood from the following detailed description of applications thereof, taken together with the drawings, in which:





BRIEF DESCRIPTION OF THE DRAWINGS


FIGS. 1A-I are schematic illustrations of an implant, in accordance with some applications of the invention;



FIGS. 2A-D are schematic illustration of a tool, in accordance with some applications of the invention;



FIGS. 3A-H are schematic illustrations showing the tool being used to deliver the implant to a native valve of a heart of a subject, in accordance with some applications of the invention;



FIGS. 4A-B, 5A-B, and 6A-B, are schematic illustrations of implant-delivery tools, in accordance with some applications of the invention; and



FIGS. 7A-H and 8A-C are schematic illustrations of additional embodiments of implant-delivery tools, in accordance with some applications of the invention.





DETAILED DESCRIPTION OF EMBODIMENTS

Reference is made to FIGS. 1A-I, which are schematic illustrations of an implant 20, in accordance with some applications of the invention.


Implant 20 comprises a tubular frame 30 that circumscribes a longitudinal axis ax1 to define a lumen 32 along axis ax1. Implant 20 typically further comprises at least one valve member (e.g., prosthetic leaflet 62) (FIG. 1I), disposed within lumen 32, and coupled to frame 30. Therefore implant 20 typically comprises or serves as a prosthetic valve 22.


Implant 20 further comprises an outer frame 40 and one or more pins 50. Outer frame 40 is disposed radially outward from tubular frame 30, comprises one or more flanges 42, and defines one or more eyelets, e.g., outer eyelets 44. Typically, frame 40 comprises a plurality of flanges (e.g., 3-18, such as 6-12, such as 8-12 flanges). Typically, frame 40 defines a plurality of eyelets 44 (e.g., 3-18, such as 6-12, such as 8-12 eyelets). For some applications, the number of eyelets 44 is equal to the number of flanges. Further typically, the number of pins 50 is equal to the number of eyelets 44. In the embodiment shown, there are 12 eyelets, 12 flanges, and 12 pins.


Typically, and as shown, frame 40 circumscribes tubular frame 30. For example, frame 40 may comprise at least one ring 46 that circumscribes tubular frame 30, and to which flanges 42 are coupled. Ring 46 typically defines alternating peaks and troughs, e.g., being zigzag or wavy in shape.


Typically, tubular frame 30 also defines one or more eyelets, e.g., inner eyelets 34. Typically, frame 30 defines a plurality of eyelets 34 (e.g., 3-18, such as 6-12, such as 8-12 eyelets). Typically, the number of eyelets 34 is equal to the number of eyelets 44.


Outer frame 40 is composed of a shape-memory alloy such as nickel titanium (e.g., Nitinol), whereas tubular frame 30 and pins 50 are composed of a material that is not the shape-memory alloy. That is, frame 30 and pins 50 are both composed of the same material, and that material is not the shape-memory alloy of which frame 40 is composed. Typically, the material of which frame 30 and pins 50 are composed is not a shape-memory material of any kind. For example, frame 30 and pins 50 may be composed of steel (e.g., stainless steel, such as 316LVM) or a cobalt chrome alloy (e.g., MP35N or L605). It is to be noted that throughout this patent application (including the specification and the claims) the term “composed of” x means that x is the primary substance from which an element is made, such that x confers its properties on the element that is made of x.


Pins 50 couple outer frame 40 to tubular frame 30. Each pin 50 defines a shaft 52 and a head 54. Shaft 52 is passed radially-inwardly through an eyelet 44 to tubular frame 30, such that head 54 is disposed against outer frame 40, radially outward from the eyelet 44. Shaft 52 is welded to tubular frame 30. Typically, shaft 52 is also passed radially inwardly through a respective eyelet 34, and is welded to tubular frame 30 at eyelet 34. Because pin 50 and frame 30 are both composed of the same material, they may be welded together. In contrast, frame 40 is composed of a different material than pin 50, and coupling therebetween is provided by head 54, which is larger than eyelet 44.


Typically, each flange 42 has a root-portion 41 and a tip 43, and extends away from the tubular frame from the root-portion to the tip. Each outer eyelet 44 is typically defined at (e.g., by) the root-portion 41 of a respective flange 42, e.g., such that the head 54 of the respective pin 50 is disposed against the root-portion of the flange, radially outward from the eyelet.


There is therefore provided, in accordance with some applications of the invention, apparatus for use in a heart of a subject, the apparatus comprising:

    • a tubular frame that circumscribes a longitudinal axis to define a lumen along the longitudinal axis;
    • a valve member, disposed within the lumen and coupled to the tubular frame;
    • an outer frame:
      • disposed radially outward from the tubular frame,
      • comprising a flange, and
      • defining an eyelet; and
    • a pin:
      • defining a shaft and a head, and
      • coupling the outer frame to the tubular frame,


wherein:

    • the outer frame is composed of a shape-memory alloy,
    • the tubular frame and the pin are composed of a material that is not the shape-memory alloy,
    • the head is disposed against the outer frame, radially outward from the eyelet,
    • the shaft extends from the head through the eyelet to the tubular frame, and
    • the shaft is welded to the tubular frame.


Typically, frame 40 is cut from a tube of the shape-memory alloy. Typically, frame 30 is cut (e.g., laser cut) from a tube of the other material. In order to facilitate implant 20 serving as a prosthetic heart valve, lumen 32 is typically lined with a lining 60 (e.g., comprising a fabric), and a plurality of prosthetic leaflets 62 (e.g., comprising bovine pericardium) are secured within the lumen, e.g., by suturing the leaflets to lining 36 and/or to frame 30. For the sake of clarity, lining 60, leaflets 62, and other fabric elements are omitted in FIGS. 1A-H.


There is therefore further provided, in accordance with some applications of the invention, a method for constructing implant 20 (e.g., a prosthetic heart valve), the method comprising:

    • from a tube of a shape-memory alloy, cutting an outer frame that comprises a flange and defines an eyelet;
    • from a tube of a material that is not the shape-memory alloy, cutting a tubular frame that circumscribes a longitudinally axis to define a lumen along the longitudinal axis;
    • positioning the outer frame against the tubular frame, radially-outward from the tubular frame;
    • passing a shaft of a pin through the eyelet such that (i) the shaft of the eyelet extends to the tubular frame, and (ii) a head of the pin is disposed against the outer frame radially outward from the eyelet, the pin being composed of the material;
    • welding the shaft to the tubular frame;
    • lining at least part of the lumen with a lining; and
    • securing a plurality of prosthetic leaflets within the lumen.


Typically, and as shown, implant 20 further comprises an upstream support portion 48, e.g., comprising a plurality of radial arms 49 optionally covered in an annular sheet. Further typically, it is outer frame 40 that defines upstream support portion 48, and therefore the upstream support portion is also composed of the shape-memory alloy. Flanges 42 extend radially outward from tubular frame 30, and toward upstream support portion 48. As discussed in more detail hereinbelow, flanges 42 are configured to engage a downstream surface of a native heart valve, and upstream support portion is configured (e.g., shaped and/or dimensioned) to be placed against an upstream surface of the native heart valve.


Frame 40 is shaped and memory-set such that, when unconstrained, upstream support portion 48 and flanges 42 extend radially outward from tubular frame 30. Typically, when unconstrained, flanges 42 are arranged in an array 56 around the outside of tubular frame 30, the array defining an inter-flange distance D58. Although inter-flange distance D58 is shown in FIG. 1G as a distance between opposing flanges 42, in some embodiments the inter-flange distance may refer to an alternative measurement (e.g., a distance between adjacent flanges 42). As discussed hereinbelow (e.g., with reference to FIGS. 3A-H), implant 20 is delivered while radially compressed (i.e., “crimped”), with upstream support portion 48 and flanges 42 constrained within a capsule. Because frame 40 is composed of the shape-memory alloy, upon being exposed from the capsule upstream support portion 48 and flanges 42 automatically deflect radially outward. In contrast, although tubular frame 30 is also radially compressed during delivery, it retains its radially-compressed state upon being exposed from the capsule, and is subsequently plastically-expanded, e.g., using a balloon. Typically, in the absence of frame 30, frame 40 (e.g., ring 46) would automatically radially expand upon being exposed from the capsule. However, because frame 40 is coupled to frame 30 (e.g., via pins 50), frame 30 inhibits frame 40 (e.g., ring 46 thereof) from radially expanding until frame 30 is plastically expanded. That is, despite the elasticity of frame 40, frame 30 is typically sufficiently rigid to inhibit frame 40 from automatically radially expanding upon exposure from the capsule. Similarly, the elasticity of frame 40 is typically insufficient to pull frame 30 into its radially expanded state (i.e., the state in which implant 20 functions as a prosthetic valve).


Reference is made to FIGS. 2A-D, which are schematic illustration of a tool 100, in accordance with some applications of the invention. For some applications, tool 100 is used to implant implant 20 at the native valve (e.g., as described with reference to FIGS. 3A-H).


Tool 100 comprises a shaft 106, a capsule 110, and a balloon 120, which is typically a non-compliant balloon. Shaft 106 has a central longitudinal shaft-axis ax2, which typically is the same as, or is collinear with, a central longitudinal axis of tool 100. Capsule 110 is disposed at a distal portion 104 of the tool (e.g., at a distal end of shaft 106), and comprises an upstream capsule-portion 112 and a downstream capsule-portion 114, and is openable by moving the upstream capsule-portion and the downstream capsule-portion apart. Balloon 120 is coupled to shaft 106, and is disposed within capsule 110 (e.g., downstream capsule-portion 114 thereof). As shown, tool 100 typically comprises a controller and/or handle 108 at a proximal portion 102 of the tool.



FIG. 2A shows tool 100 in a closed state, with capsule-portions 112 and 114 close to each other (e.g., in contact with each other). FIG. 2B shows tool 100 in an open state, after capsule 110 has been opened by retracting capsule-portion 114 away from capsule-portion 112. FIG. 2C shows a longitudinal cross-section of FIG. 2B. FIG. 2D shows the same longitudinal cross-section as FIG. 2C, but with balloon 120 inflated. For clarity, implant 20 is not shown in FIGS. 2A-D.


As described hereinabove, outer frame 40 of implant 20 is composed of a shape-memory alloy. Flanges 42 are shape-set to protrude radially outward. Upstream support portion 48 is (e.g., arms 49 thereof are) also shape-set to protrude radially outward. As described in more detail with reference to FIGS. 3A-H, flanges 42 and upstream support portion 48 are disposed within, and constrained radially inward by, capsule 110 during delivery. For example, flanges 42 may be constrained by downstream capsule-portion 114 (e.g., constrained within the downstream capsule-portion), and upstream support portion 48 may be constrained by upstream capsule-portion 112 (e.g., constrained within the upstream capsule-portion). For delivery of implant 20, tubular frame 30 is compressed around balloon 120, which will eventually be used to radially expand the tubular frame. Typically, during delivery tubular frame 30 is disposed within downstream capsule-portion 114. Therefore, in preparation for implantation of implant 20, an operator typically compresses (e.g., “crimps”) tubular frame 30 around balloon 120, radially compresses and at least partly encapsulates flanges 42 within downstream capsule-portion 114, and radially compresses and at least partly encapsulates upstream support portion 48 (e.g., arms 49 thereof) within upstream capsule-portion 112.


In the delivery state of the apparatus, balloon 120 is typically disposed within capsule 110, flanges 42 are typically constrained within downstream capsule-portion 114, and upstream support portion 48 is typically constrained within upstream capsule-portion 112. For some applications, the term “within” means “entirely within,” i.e., with no part of the balloon, flange, or upstream support portion disposed outside of the capsule or capsule-portion. For some applications, the term “within” means “at least partly within,” i.e., part of the balloon, flange, or upstream support portion may be disposed outside of the capsule or capsule-portion.


There is therefore provided, in accordance with some applications of the invention, apparatus comprising:

    • a delivery tool, comprising:
      • a shaft, having a shaft-axis;
      • a capsule, disposed at a distal portion of the tool, and comprising an upstream capsule-portion and a downstream capsule-portion, the capsule being openable by moving the upstream capsule-portion and the downstream capsule-portion apart; and
      • a balloon, coupled to the shaft, and disposed within the capsule; and a prosthetic valve, comprising:
      • a tubular frame, compressed around the balloon, and disposed within the capsule;
      • one or more shape-memory flanges, constrained within the downstream capsule-portion; and
      • a shape-memory upstream support portion, constrained within the upstream capsule-portion,


wherein:

    • the flanges are configured to automatically deflect radially outward upon exposure of the tubular frame from the downstream capsule-portion,
    • the upstream support portion is configured to automatically deflect radially outward upon exposure from the upstream capsule-portion,
    • the tubular frame is configured to remain compressed around the balloon upon exposure from the capsule, and
    • while the tubular frame is exposed from the capsule, inflation of the balloon plastically expands the tubular frame radially.


Balloon 120 has an upstream (e.g., distal) balloon-portion 122, a downstream (e.g., proximal) balloon-portion 126, and a body (e.g., intermediary) balloon-portion 124 therebetween. Body balloon-portion 124 typically comprises the widest part of balloon 120. Typically, body balloon-portion 124 is disposed within lumen 32 of tubular frame 30. That is, for delivery, tubular frame 30 is typically compressed around body balloon-portion 25. As shown in FIG. 2D, when inflated, body balloon-portion 124 is typically cylindrical, and balloon-portions 122 and 126 typically taper away from the body balloon-portion and from tubular frame 30. For example, balloon-portions 126 and 126 may be conical or hemispherical.


Typically, balloon 120 is fixed to shaft 106, e.g., by at least one end of the balloon being attached to the shaft. For example, and as shown, balloon-portion 124 may be attached to shaft 106. Tool 100 defines an inflation channel 119 from proximal portion 102 to distal portion 104. For some applications, and as shown, tool 100 comprises a pipe 118 through which shaft 106 extends, and channel 119 is defined between the pipe and the channel. For such applications, balloon-portion 126 of balloon 120 is typically attached to pipe 118, placing balloon 120 in fluid communication with channel 119 such that the balloon is inflatable via the channel.


Typically, pipe 118 is fixed with respect to shaft 106. However, both upstream capsule-portion 112 and downstream capsule-portion 114 are typically axially movable with respect to shaft 106, such as by one of the capsule-portions being attached to a rod 116 that is slidable through the shaft, and the other one of the capsule-portions being attached to a tube (not shown) that is slidable over the shaft. For example, and as shown, capsule-portion 112 may be attached to rod 116, and capsule-portion 114 may be attached to the tube. Upstream capsule-portion 112 is retractable from over upstream support portion 48 by being moved away from balloon 120 (i.e., in an upstream direction), and downstream capsule-portion 114 is retractable from over flanges 42 by being moved away from the balloon (i.e., in a downstream direction).


Typically, tool 100 comprises one or more (typically a plurality of) elongate projections 130. Projections 130 are configured to apply an axial pushing force against implant 20 (e.g., tubular frame 30 thereof), in order to maintain the positioning of the implant during deployment. For example, and as described in more detail with reference to FIGS. 3A-H, after flanges 42 are exposed and allowed to expand, the flanges may be pushed and held against a downstream surface of the native valve (e.g., leaflets thereof), typically until balloon 120 is at least partly inflated. Typically, each of projections 130 is sufficiently stiff (e.g., axially stiff) that, when pushed against tubular frame 30, it is capable of applying an axial pushing force of at least 0.5 N, e.g., at least 5 N, such as at least 10 N—e.g., without the projection buckling. For example, each projection 130 may be capable of applying a pushing force of 0.5-50 N, e.g., 0.5-20 N (e.g., 0.5-15 N) or 5-50 N (e.g., 5-20 N, e.g., 5-15 N, such 5-10 N or 10-15 N). Typically, projections 130 are collectively capable of applying an axial pushing force of at least 3 N, (e.g., at least 6 N, e.g., at least 20 N, e.g., at least 40 N, such as at least 60 N) to tubular frame 30—e.g., without the projection buckling. For example, projections 130 may be collectively capable of applying a pushing force of 3-100 N e.g., 3-30 N (e.g., 6-30 N) or 40-100 N (e.g., 40-80 N or 60-100 N). For clarity, these axial pushing force values are as measured with the projection or projections aligned parallel to axis ax1.


During delivery (i.e., in a delivery state of tool 100 and implant 20), projections 130 are typically disposed within downstream capsule-portion 114. Each projection 130 has a tip-portion (e.g., a free end) 132, and a base-portion 134. Base-portion 134 is disposed deeper into the downstream capsule-portion than is tip-portion 132. Projections 130 are arranged circumferentially around shaft-axis ax2, such that tip-portions 132 are arranged circumferentially around balloon-portion 126 of balloon 120, with the tip-portion of each projection being closer than its corresponding base-portion 134 to tubular frame 30. Typically, in the delivery state, tip-portions 132 abut tubular frame 30 (e.g., a proximal and/or downstream surface thereof). However, projections 130 (e.g., tip-portions 132 thereof) are typically not attached to tubular frame 30. Therefore, after expansion of tubular frame 30 and deflation of balloon 120 (e.g., as described with reference to FIGS. 3A-H), projections 130 can be withdrawn without actively disengaging them from the tubular frame.


Tool 100 is typically configured to facilitate continued application, by projections 130, of the axial pushing force against tubular frame 30 while the tubular frame is being expanded, despite the presence of tapered balloon-portion 126. This feature, and its advantages, are discussed in more detail hereinbelow with reference to FIGS. 4A-B, 5A-B, and 6A-B. Once tubular frame 30 and tip-portions 132 are exposed from downstream capsule-portion 114, inflation of balloon 120 both (i) radially expands the tubular frame (e.g., by body balloon-portion 124 pressing radially outward against the tubular frame), and (ii) deflects each of projections 130 radially outward (e.g., by balloon-portion 124 pressing radially outward against the projection).


The apparatus may be configured such that projections 130 deflect simultaneously and/or at the same rate that the tubular frame expands, allowing contact between the projections and the tubular frame to be maintained. For example, tubular frame 30 may define a frame-circumference, the tip-portions may collectively define a projection-circumference, and while the tubular frame and the tip-portions are exposed from the downstream capsule-portion, inflation of balloon 120 may increase the projection-circumference at the same rate as it increases the frame-circumference.


Each projection 130 is therefore sufficiently flexible (e.g., radially flexible) that it is deflected by a radial force F1 applied by the radial expansion of balloon-portion 126. Nonetheless, as described hereinabove, each projection 130 is also typically capable of applying an axial pushing force F2 of at least 0.5 N to tubular frame 30 (e.g., to overcome an axial resistance force F3, of frame 30 against the projections, in the opposite direction of force F2). Forces F1, F2, and F3 are indicated in FIG. 4B.


For some applications of the invention, this configuration is facilitated by each projection 130 being non-isometrically flexible. For example, each projection 130 may have a radial stiffness in its radial plane 136, and a lateral stiffness in its lateral plane 138, the lateral stiffness being greater than (e.g., more than twice as great as) the radial stiffness. For clarity, radial plane 136 is a plane on which the projection and axis ax2 lie, and in which the projection deflects, and lateral plane 138 is typically transverse to the radial plane. Lateral plane 138 may also be tangential to the projection-circumference collectively defined by the tip-portions of projections 130.


For some applications of the invention, outward radial force F1 is of a greater magnitude than axial resistance force F3. It is hypothesized by the inventors that, for at least some such applications of the invention, F1 being greater than F3 facilitates deflection of projections 130 simultaneously with the projections axially pushing tubular frame 30.


For some applications, and as shown, tip-portions 132 are shaped to define a face that has a greater transverse cross-sectional area than parts of projection 130 that are closer to base-portion 134. These faces are visible in FIGS. 2C-D. The difference in transverse cross-sectional area may be understood by comparing the element labeled “130” in the lower cross-section of FIG. 3B, with the element labeled “130, 132” in the upper cross-section of FIG. 3B. It is hypothesized by the inventors that, due to their greater transverse cross-sectional area, these faces facilitate application of the axial pushing force to tubular frame 30.


Reference is now made to FIGS. 3A-H, which are schematic illustrations showing tool 100 being used to deliver implant 20 to a native valve 10 of a heart 4 of a subject, in accordance with some applications of the invention. Although FIGS. 3A-H show a percutaneous transapical approach, it is to be noted that the scope of the present invention includes other percutaneous approaches, such as transatrial, or transluminal (e.g., transfemoral), mutatis mutandis. It is to be noted that the scope of the present invention includes modifications to tool 100 that facilitate these approaches. Although FIGS. 3A-H show valve 10 as being a mitral valve, it is to be noted that the scope of the present invention includes the native valve being a tricuspid valve, an aortic valve, or a pulmonary valve, mutatis mutandis.


While tool 100 and implant 20 are in the delivery state (e.g., with capsule 110 closed, and implant 20 compressed therewithin), tool 100 is transapically advanced into left ventricle 8 (FIG. 3A). For some applications, and as shown, tool 100 is positioned (e.g., facilitated by fluoroscopy) such that capsule-portion 112 is disposed between native leaflets 12 of valve 10. Capsule-portion 114 is then retracted, in a downstream direction, away from capsule-portion 112, exposing (i) at least flanges 42 of implant 20, and (ii) at least tip-portions 132 of projections 130 (FIG. 3B). Flanges 42 automatically deflect radially outward upon becoming exposed. Typically, and as shown in the inset of FIG. 3C, flanges 42 are arranged in array 56 around the outside of tubular frame 30, the array defining inter-flange distance D58. Typically, this step also exposes tubular frame 30 from capsule-portion 114. As described hereinabove, tubular frame 30 typically does not expand upon becoming exposed from capsule-portion 114.



FIG. 3B includes two cross-sections. The upper cross-section is at the level of contact between projections 130 and implant 20, and therefore shows tip-portions 132 of the projections arranged circumferentially around uninflated balloon 120, through which shaft 106 extends. The lower cross-section is further downstream/proximal, closer to base-portions 134 of projections 130. The lower cross-section also shows, for one projection 130, a radial plane 136 and a lateral plane 138. As described hereinabove, radial plane 136 is a plane on which projection 130 and axis ax1 lie, and in which the projection deflects, and lateral plane 138 is typically transverse to the radial plane.


Flanges 42 are subsequently pressed against a downstream surface of native valve 10 by moving implant 20 in an upstream direction (FIG. 3C). This is performed by applying, via projections 130, the axial pushing force described hereinabove. Typically, flanges 42 are pressed against leaflets 12 of the native valve.


As shown in FIG. 3C, for applications in which prosthetic valve 22 comprises upstream support portion 48, this movement of implant 20 includes placing the upstream support portion, constrained by capsule-portion 112, upstream of native valve 10 (i.e., into left atrium 6). For such applications, projections 130 typically facilitate retention of upstream support portion 48 within capsule-portion 112 by obstructing implant 20 from moving axially away from the capsule-portion.


Subsequently, upstream support portion 48 is exposed from capsule-portion 112 and automatically deflects radially outward, e.g., contacting an upstream surface of native valve 10 (FIG. 3D).


While flanges 42 remain in contact with the downstream surface of the native valve, and typically while upstream support portion 48 remains in contact with the upstream surface of the native valve, tubular frame 30 is plastically expanded radially by inflating balloon 120 (FIGS. 3E-F). For some applications, this is performed while continuing to press flanges 42 against the downstream surface using projections 130. As described hereinabove, projections 130 are configured to deflect radially outwardly as tubular frame 30 expands upon inflation of balloon 120, and therefore (i) do not inhibit radial expansion of the balloon, and (ii) facilitate optional continued application of the axial pushing force during inflation of the balloon.


After implant 20 has been implanted and expanded, balloon 120 is deflated, and tool 100 is removed from the subject, typically after closing capsule 110 (FIGS. 3G-H).


Reference is now made to FIGS. 4A-B, 5A-B, and 6A-B, which are schematic illustrations of implant-delivery tools 100, 200, and 300, in accordance with some applications of the invention. In FIGS. 4A-B, 5A-B, and 6A-B, a generic expandable implant 180 is shown being implanted using the respective tool. For some applications, implant 180 may represent tubular frame 30 of implant 20.



FIGS. 4A-B show tool 100 being used with implant 180, e.g., as described hereinabove for implant 20. The states of tool 100 in FIGS. 4A-B generally correspond to the state of tool 100 in FIGS. 2C-D, respectively, except that in FIGS. 4A-B implant 180 is shown. That is, (i) FIG. 4A shows implant 180 disposed around body balloon-portion 124 of balloon 120, with downstream capsule-portion 114 having been withdrawn, and balloon 120 not yet inflated, and (ii) FIG. 4B shows balloon 120 having been inflated. FIGS. 5A-B and 6A-B show the same states (e.g., the same steps of deployment) for tools 200 and 300.


Tool 200 is identical to tool 100, except that it comprises projections 230 instead of projections 130. Projections 230 are identical to projections 130, except that they are more rigid. Projections 330 are identical to projections 130 except that they are shorter, and therefore do not extend over balloon-portion 126 to implant 180. (Projections 330 may be flexible like projections 130 or rigid like projections 230.) As described hereinabove, tool 100 is typically configured to facilitate continued application, by projections 130, of the axial pushing force against tubular frame 30 while the tubular frame is being expanded, despite the presence of tapered balloon-portion 126. The advantage conferred by projections 130 may be illustrated by the following comparison of the results of using tool 200 and/or tool 300, to the result of using tool 100.


As described hereinabove, body balloon-portion 124 is typically cylindrical, and balloon-portions 122 and 126 typically taper away from the body balloon-portion. A balloon of this shape advantageously can withstand a greater inflation pressure than can a similar balloon that is entirely cylindrical (i.e., with flat ends). However, in order to expand implant 180 evenly, the implant is disposed around body balloon-portion 124, which is cylindrical when inflated.


Before inflation of balloon 120, there is no difference between using tool 100 and using tool 200. When balloon 120 of tool 100 is inflated, projections 130 are pushed radially outward by the balloon, allowing downstream balloon-portion 126 (over which the projections are disposed) to assume its conical shape, and body balloon-portion 124 to assume its cylindrical shape, thereby evenly expanding implant 180. When inflated, balloon 120 typically fills the lumen of implant 180 uniformly.


In contrast, when balloon 120 of tool 200 is inflated, projections 130 are not pushed radially outward by the balloon, and instead constrain balloon-portion 126 (over which the projections are disposed) from expanding. Therefore, a downstream region 124a of body balloon-portion 124 is inhibited from fully inflating and joining the rest of the body balloon-portion in becoming cylindrical. Therefore, the part of implant 180 that is disposed around region 124a is not expanded to the same degree as other parts of the implant. That is, implant 180 is not expanded evenly.


Projections 330 of tool 300 do not extend over balloon-portion 126 to implant 180, and therefore do not constrain balloon-portion 126 from expanding. However, because they do not reach implant 180, they are unable to serve the function of applying the axial force to the implant in order to correctly position the implant during implantation. Furthermore, in some instances, implant 180 may slip with respect to balloon 120 and become positioned over conical balloon-portion 126 or 122, which, as described hereinabove, may result in uneven expansion of the implant.


Therefore, the particular quality of projections 130 to be both (i) sufficiently rigid to apply the axial force to an implant, and (ii) sufficiently radially flexible to be pushed radially outward by balloon 120, provides tool 100 with the ability to both (i) control the position of an implant, and (ii) to evenly expand the implant.


Reference is made to FIGS. 7A-H and 8A-C, which are schematic illustrations of additional embodiments of implant-delivery tool 100 being used to deliver implant 20 to a native valve 10 of a heart 4 of a subject, in accordance with some applications of the invention. In such embodiments, balloon 120 is configured to be expandable to at least (i) a partially-inflated state and (ii) a further-inflated state. For example, proximal portion 102 of tool 100 (e.g., controller/handle 108) may be configured to inflate balloon 120 to a distinct partially-inflated state, and may be further configured to inflate balloon 120 to a further-inflated state. It is hypothesized by the inventors that regulated inflation of balloon 120, such that the balloon may be maintained in the partially-inflated state, may facilitate some applications of tool 100, as described hereinbelow. Since such embodiments share similarities with those described above in reference to FIGS. 3A-H, the following description will focus upon aspects differentiating between them and the embodiments described hereinabove in reference to FIGS. 3A-H.


Although FIGS. 7A-H and 8A-C show a transapical approach to a native mitral valve, these embodiments of the invention may also be modified as necessary to accommodate alternate approaches to a mitral or other native heart valve, mutatis mutandis. FIG. 7A shows tool advanced while implant 20 is disposed within capsule 110, from which the implant is later exposed. Typically, and as shown in FIG. 7B, flanges 42 deflect automatically radially outward upon exposure from capsule 110, whereas tubular frame 30 typically does not expand upon being partially or entirely exposed from the capsule. Further typically, and as shown, capsule 110 comprises upstream capsule-portion 112 and downstream capsule-portion 114, and flanges 42 are exposed from the capsule by moving the downstream capsule-portion away from the upstream capsule-portion. Further typically, flanges 42 are (i) exposed from the downstream capsule-portion and (ii) arranged in array 56 around the outside of tubular frame 30, before the flanges are pressed against the downstream surface of the native valve 10.


For some applications, it may be desirable to at least partially expand tubular frame and/or array 56 of flanges 42, prior to the flanges contacting the downstream surface of native valve 10. FIG. 7C shows inflation of balloon 120 to the partially-inflated state, before flanges 42 contact the surface of the native valve 10. Inflation of balloon 120 to the partially-inflated state enacts, inter alia, (i) partial radial expansion of tubular frame 30, and/or (ii) partial increasing of inter-flange distance D58 defined by array 56. FIG. 7D shows pressing of flanges 42 against a downstream surface of the native valve 10 by moving implant 20 in an upstream direction, while inter-flange distance D58 remains partially increased. Typically, and as shown, this is achieved by moving the implant in the upstream direction while balloon 120 remains in the partially-inflated state. In this way, partial inflation of balloon 120 may enable flanges to reach further laterally while contacting the downstream surface of native valve 10. It is hypothesized by the inventors that increasing inter-flange distance D58 defined by array 56, before flanges 42 press against the downstream surface, may facilitate capture of the tissue of native valve 10 (e.g., native leaflets 12)—e.g., increasing an amount of the tissue eventually captured between flanges 42 and upstream support portion 48.


Subsequently, upstream support portion 48 is exposed from capsule 110 while flanges 42 remain in contact with the downstream surface (e.g., continue to press against the downstream surface), while inter-flange distance D58 remains partially increased, and typically while balloon 120 remains partially inflated (FIG. 7E). This may be analogous to the step shown in FIG. 3D, but with inter-flange distance D58 partially increased, and balloon 120 typically being partially inflated.


Subsequently, balloon 120 is further inflated to the further-inflated state further radially expanding tubular frame 30 (FIG. 7F). For some applications, this also further increases inter-flange distance D58 by expanding array 56. That is, further inflation of balloon 120 may enable the flanges to reach further laterally than when balloon 120 is in the partially-inflated state.



FIGS. 7G-H show subsequent deflation of balloon 120 and withdrawal of tool 100, e.g., analogous to FIGS. 3G-H, mutatis mutandis.


For some applications, it may be desirable to expose flanges 42 from capsule 110 and/or at least partially expand array 56, while the flanges are disposed upstream of the native valve 10 (e.g., within atrium 6), and to subsequently move the flanges downstream of the native valve (e.g., within ventricle 8) while the flanges remain in this state. FIGS. 8A-C relate to such applications.



FIG. 8A shows exposure of flanges disposed upstream of native valve 10, in accordance with some applications of the invention. Prior to this, tool 100 is typically positioned within the heart such that the flanges are disposed, within capsule 110, upstream of the native valve.


For some applications, and as shown in FIG. 8B, balloon 120 is then inflated to the partially-inflated state, while flanges 42 remain disposed upstream of native valve 10.


Subsequently, tool 100 is moved downstream (proximally, for a transapical approach) until the leaflets are observed (e.g., using fluoroscopy and/or ultrasound) to coapt upstream of flanges 42 (FIG. 8C). It is hypothesized by the inventors that this reduces how far downstream the flanges become disposed while deployed. That is, the position of implant 20 at which the leaflets coapt upstream of the flanges represents the minimal depth into the ventricle that the flanges are required to reach in order to subsequently ensnare the leaflets. This therefore reduces the distance that the deployed flanges must be moved in an upstream direction when subsequently engaging the leaflets. It is hypothesized by the inventors that this reduces the likelihood of inadvertently or prematurely ensnaring tissue such as chordae tendineae, which might otherwise occur if the deployed flanges were deeper within the ventricle, and therefore moved a greater distance, while in their deployed state, upstream through the ventricle. Similar techniques are described, mutatis mutandis, in U.S. Pat. No. 10,492,908 to Hammer et al. and in U.S. Pat. No. 9,974,651 to Hariton et al., which is the US national phase of WO 2016/125160 to Hariton et al., all of which are incorporated herein by reference.


For some applications in which flanges 42 are exposed upstream of the native valve, balloon 120 is partially inflated only after the exposed flanges are moved downstream of the native valve (embodiment not shown).


There is therefore provided, in accordance with some applications of the invention, method comprising:


advancing, to the heart:

    • a distal portion of a delivery tool, the delivery tool including:
      • a shaft that extends to the distal portion of the delivery tool,
      • a capsule disposed at the distal portion of the delivery tool, and
      • a balloon, coupled to the shaft, and
    • an implant disposed within the capsule, and including a tubular frame and an array of shape-memory flanges arranged around an outside of the tubular frame, the tubular frame compressed around the balloon, and the flanges constrained within the capsule;


subsequently, exposing the flanges from the capsule such that the flanges automatically deflect radially outward away from the tubular frame, and such that the array defines an inter-flange distance;


subsequently, by partially inflating the balloon to a partially-inflated state:

    • (i) partially radially expanding the tubular frame, and (ii) partially increasing the inter-flange distance;


while the balloon remains in the partially-inflated state, pressing the flanges against a downstream surface of the native valve by moving the implant in an upstream direction; and


subsequently, by further inflating the balloon to a further-inflated state, further radially expanding the tubular frame.


There is further provided, in accordance with some applications of the invention (e.g., as described in reference to FIGS. 8A-C) a method in which:


exposing the flanges comprises exposing the flanges while the flanges are positioned upstream of the native valve; and


the method further comprises, prior to pressing the flanges against the downstream surface of the native valve, moving the exposed flanges to be downstream of the native valve.


It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.

Claims
  • 1. Apparatus for use at a native valve of a heart of a subject, the apparatus comprising: a delivery tool, comprising: a shaft, having a shaft-axis;a capsule, disposed at a distal portion of the tool, and comprising an upstream capsule-portion and a downstream capsule-portion, the capsule being openable by moving the upstream capsule-portion and the downstream capsule-portion apart; anda balloon, coupled to the shaft, and disposed within the capsule; anda prosthetic valve, comprising: a tubular frame that circumscribes a longitudinal axis to define a lumen along the longitudinal axis, that is compressed around the balloon, and that is disposed within the capsule; andan outer frame, the outer frame comprising: one or more shape-memory flanges, constrained within the downstream capsule-portion; anda shape-memory upstream support portion, constrained within the upstream capsule-portion,
  • 2. The apparatus according to claim 1, wherein the prosthetic valve further comprises one or more prosthetic valve leaflets disposed within the lumen and coupled to the tubular frame.
  • 3. The apparatus according to claim 1, wherein the tubular frame is disposed within the downstream capsule-portion of the capsule.
  • 4. The apparatus according to claim 1, wherein the tubular frame is composed of a material that is not a shape-memory alloy.
  • 5. The apparatus according to claim 4, wherein the tubular frame is composed of steel.
  • 6. The apparatus according to claim 4, wherein the tubular frame is composed of cobalt chrome.
  • 7. The apparatus according to claim 1, wherein the flanges are composed of a shape-memory alloy.
  • 8. The apparatus according to claim 7, wherein the flanges are composed of nickel titanium.
  • 9. The apparatus according to claim 1, wherein the balloon is fixed to the shaft.
  • 10. The apparatus according to claim 9, wherein both the upstream capsule-portion and the downstream capsule-portion are axially movable with respect to the shaft.
  • 11. The apparatus according to claim 10, wherein: a first capsule-portion selected from the group consisting of: the upstream capsule-portion and the downstream capsule-portion is attached to a tube, and is axially movable with respect to the shaft by the tube being slid over the shaft, anda second capsule-portion selected from the group is attached to a rod, and is axially movable with respect to the shaft by the rod being slid though the shaft.
  • 12. The apparatus according to claim 9, wherein the upstream capsule-portion is retractable from over the upstream support portion by being moved away from the balloon, and the downstream capsule-portion is retractable from over the flanges by being moved away from the balloon.
  • 13. The apparatus according to claim 1, wherein the delivery tool further comprises one or more elongate projections disposed within the downstream capsule-portion, each of the projections having (i) a tip-portion, and (ii) a base-portion, disposed deeper than the tip-portion into the downstream capsule-portion, the projections arranged circumferentially around the shaft-axis such that the tip-portions are arranged circumferentially around a downstream balloon-portion of the balloon, with the tip-portion of each projection being closer than its corresponding base-portion to the tubular frame.
  • 14. The apparatus according to claim 13, wherein each of the projections is sufficiently stiff that, when pushed against the tubular frame, it is capable of applying, to the tubular frame, an axial pushing force of at least 0.5 N.
  • 15. The apparatus according to claim 13, wherein each of the projections is sufficiently stiff that, when pushed against the tubular frame, the one or more projections are capable collectively of applying, to the tubular frame, an axial pushing force of at least 3 N.
  • 16. The apparatus according to claim 13, wherein the tubular frame is disposed within the downstream capsule-portion of the capsule, and wherein the downstream capsule-portion is retractable from over the tubular frame and at least the tip-portions, exposing, from the downstream capsule-portion, the tubular frame and at least the tip-portions.
  • 17. The apparatus according to claim 16, wherein, while the tubular frame and the tip-portions are exposed from the downstream capsule-portion, inflation of the balloon (i) radially expands the tubular frame, and (ii) deflects each of the projections radially outward within a respective radial plane on which the shaft-axis and the projection lie.
  • 18. The apparatus according to claim 17, wherein, while the tubular frame and the tip-portions are exposed from the downstream capsule-portion, inflation of the balloon uniformly fills the lumen of the tubular frame.
  • 19. The apparatus according to claim 17, wherein a widest part of the balloon is disposed within the lumen.
  • 20. The apparatus according to claim 17, wherein each projection has a radial stiffness in its radial plane, and has a lateral stiffness in a respective lateral plane, the lateral stiffness being greater than the radial stiffness.
  • 21. The apparatus according to claim 16, wherein: the balloon has an upstream balloon-portion, a downstream balloon-portion, and a body balloon-portion therebetween,the tubular frame is compressed around the body balloon-portion, andwhile the tubular frame and the tip-portions are exposed from the downstream capsule-portion, inflation of the balloon (i) radially expands the tubular frame by pressing the body balloon-portion radially outward against the tubular frame, and (ii) deflects the projections radially outward by pressing the downstream balloon-portion radially outward against the projections.
  • 22. The apparatus according to claim 21, wherein the downstream balloon-portion of the balloon extends away from the tubular frame, and is tapered.
  • 23. The apparatus according to claim 21, wherein the upstream balloon-portion of the balloon extends away from the tubular frame, and is tapered.
  • 24. The apparatus according to claim 21, wherein the tip-portion of each of the projections abuts the tubular frame, and the apparatus is configured such that the tip-portion of each of the projections remains in contact with the tubular frame as the balloon is inflated.
  • 25. The apparatus according to claim 21, wherein a downstream end of the tubular frame defines a frame-circumference, the tip-portions define a projection-circumference, and while the tubular frame and the tip-portions are exposed from the downstream capsule-portion, inflation of the balloon increases the projection-circumference at the same rate as the balloon increases the frame-circumference.
  • 26. The apparatus according to claim 13, wherein the tip-portion of each of the projections abuts the tubular frame.
  • 27. The apparatus according to claim 26, wherein the projections are not attached to the tubular frame.
  • 28. The apparatus according to claim 1, wherein the flanges are configured such that, upon exposure of the tubular frame from the downstream capsule-portion, the flanges automatically deflect: radially outward from the tubular frame, andtoward the upstream support portion.
Priority Claims (1)
Number Date Country Kind
1720803 Dec 2017 GB national
PCT Information
Filing Document Filing Date Country Kind
PCT/IL2018/051350 12/12/2018 WO 00
Publishing Document Publishing Date Country Kind
WO2019/116369 6/20/2019 WO A
US Referenced Citations (1106)
Number Name Date Kind
3874388 King et al. Apr 1975 A
4222126 Boretos et al. Sep 1980 A
4261342 Aranguren Apr 1981 A
4275469 Gabbay Jun 1981 A
4340091 Skelton et al. Jul 1982 A
4423525 Vallana et al. Jan 1984 A
4853986 Allen Aug 1989 A
4892541 Alonso Jan 1990 A
4972494 White et al. Nov 1990 A
4994077 Dobben Feb 1991 A
5078739 Martin Jan 1992 A
5108420 Marks Apr 1992 A
5201757 Heyn Apr 1993 A
5314473 Godin May 1994 A
5332402 Teitelbaum Jul 1994 A
5397351 Pavcnik et al. Mar 1995 A
5405378 Strecker Apr 1995 A
5443500 Sigwart Aug 1995 A
5473812 Morris et al. Dec 1995 A
5607444 Lam Mar 1997 A
5607470 Milo Mar 1997 A
5647857 Anderson et al. Jul 1997 A
5702397 Goble et al. Dec 1997 A
5713948 Uflacker Feb 1998 A
5716417 Girard et al. Feb 1998 A
5741297 Simon Apr 1998 A
5765682 Bley et al. Jun 1998 A
5776140 Cottone Jul 1998 A
5868777 Lam Feb 1999 A
5873906 Lau et al. Feb 1999 A
5954766 Zadno-Azizi et al. Sep 1999 A
5957949 Leonhardt et al. Sep 1999 A
5980565 Jayaraman Nov 1999 A
6010530 Goicoechea Jan 2000 A
6019787 Richard et al. Feb 2000 A
6042607 Williamson, IV Mar 2000 A
6059827 Fenton May 2000 A
6074417 Peredo Jun 2000 A
6113612 Swanson et al. Sep 2000 A
6120534 Ruiz Sep 2000 A
6126686 Badylak et al. Oct 2000 A
6152937 Peterson et al. Nov 2000 A
6165183 Kuehn et al. Dec 2000 A
6165210 Lau et al. Dec 2000 A
6187020 Zegdi et al. Feb 2001 B1
6193686 Estrada et al. Feb 2001 B1
6193745 Fogarty et al. Feb 2001 B1
6254609 Vrba Jul 2001 B1
6264700 Kilcoyne et al. Jul 2001 B1
6287339 Vasquez et al. Sep 2001 B1
6312465 Griffin et al. Nov 2001 B1
6332893 Mortier et al. Dec 2001 B1
6334873 Lane et al. Jan 2002 B1
6346074 Roth Feb 2002 B1
6350278 Lenker et al. Feb 2002 B1
6352561 Leopold et al. Mar 2002 B1
6391036 Berg et al. May 2002 B1
6402780 Williamson, IV Jun 2002 B2
6409755 Vrba Jun 2002 B1
6419696 Ortiz et al. Jul 2002 B1
6428550 Vargas et al. Aug 2002 B1
6440164 Dimatteo et al. Aug 2002 B1
6454799 Schreck Sep 2002 B1
6458153 Bailey et al. Oct 2002 B1
6478807 Foreman et al. Nov 2002 B1
6482228 Norred Nov 2002 B1
6491711 Durcan Dec 2002 B1
6511491 Grudem et al. Jan 2003 B2
6530952 Vesely Mar 2003 B2
6540782 Snyders Apr 2003 B1
6551350 Thornton et al. Apr 2003 B1
6558396 Inoue May 2003 B1
6558418 Carpentier et al. May 2003 B2
6569196 Vesely May 2003 B1
6602263 Swanson et al. Aug 2003 B1
6616675 Evard et al. Sep 2003 B1
6652556 VanTassel et al. Nov 2003 B1
6669724 Park et al. Dec 2003 B2
6682558 Tu et al. Jan 2004 B2
6699256 Logan et al. Mar 2004 B1
6716244 Klaco Apr 2004 B2
6719781 Kim Apr 2004 B1
6719788 Cox Apr 2004 B2
6730118 Spenser et al. May 2004 B2
6733525 Yang et al. May 2004 B2
6752813 Goldfarb et al. Jun 2004 B2
6764518 Godin Jul 2004 B2
6767362 Schreck Jul 2004 B2
6797002 Spence et al. Sep 2004 B2
6821297 Snyders Nov 2004 B2
6830585 Artof et al. Dec 2004 B1
6830638 Boylan et al. Dec 2004 B2
6884257 Cox et al. Apr 2005 B1
6893460 Spenser et al. May 2005 B2
6926715 Hauck et al. Aug 2005 B1
6951571 Srivastava Oct 2005 B1
6960217 Bolduc Nov 2005 B2
6964684 Ortiz et al. Nov 2005 B2
6974476 McGuckin et al. Dec 2005 B2
7011681 Vesely Mar 2006 B2
7018406 Seguin et al. Mar 2006 B2
7041132 Quijano et al. May 2006 B2
7074236 Rabkin Jul 2006 B2
7077861 Spence Jul 2006 B2
7101395 Tremulis et al. Sep 2006 B2
7101396 Artof et al. Sep 2006 B2
7137184 Schreck Nov 2006 B2
7172625 Shu et al. Feb 2007 B2
7175656 Khairkhahan Feb 2007 B2
7198646 Figulla et al. Apr 2007 B2
7201772 Schwammenthal Apr 2007 B2
7226467 Lucatero et al. Jun 2007 B2
7226477 Cox Jun 2007 B2
7261686 Couvillon, Jr. Aug 2007 B2
7288097 Séguin Oct 2007 B2
7288111 Holloway et al. Oct 2007 B1
7316716 Egan Jan 2008 B2
7329279 Haug et al. Feb 2008 B2
7335213 Hyde et al. Feb 2008 B1
7351256 Hojeibane et al. Apr 2008 B2
7374573 Gabbay May 2008 B2
7377938 Sarac et al. May 2008 B2
7381218 Schreck Jun 2008 B2
7381219 Salahieh et al. Jun 2008 B2
7404824 Webler et al. Jul 2008 B1
7422603 Lane Sep 2008 B2
7429269 Schwammenthal Sep 2008 B2
7442204 Schwammenthal Oct 2008 B2
7445630 Lashinski et al. Nov 2008 B2
7455677 Vargas et al. Nov 2008 B2
7455688 Furst et al. Nov 2008 B2
7462162 Phan et al. Dec 2008 B2
7481838 Carpentier et al. Jan 2009 B2
7510575 Spenser et al. Mar 2009 B2
7513909 Lane et al. Apr 2009 B2
7527646 Randert et al. May 2009 B2
7556632 Zadno Jul 2009 B2
7556646 Yang et al. Jul 2009 B2
7563267 Goldfarb et al. Jul 2009 B2
7563273 Goldfarb et al. Jul 2009 B2
7582111 Krolik et al. Sep 2009 B2
7585321 Cribier Sep 2009 B2
7597711 Drews et al. Oct 2009 B2
7608091 Goldfarb et al. Oct 2009 B2
7611534 Kapadia et al. Nov 2009 B2
7621948 Hermann et al. Nov 2009 B2
7625403 Krivoruchko Dec 2009 B2
7632302 Vreeman et al. Dec 2009 B2
7635329 Goldfarb et al. Dec 2009 B2
7648528 Styrc Jan 2010 B2
7655015 Goldfarb et al. Feb 2010 B2
7682380 Thornton et al. Mar 2010 B2
7708775 Rowe et al. May 2010 B2
7717952 Case et al. May 2010 B2
7717955 Lane et al. May 2010 B2
7731741 Eidenschink Jun 2010 B2
7736388 Goldfarb et al. Jun 2010 B2
7748389 Salahieh et al. Jul 2010 B2
7753922 Starksen Jul 2010 B2
7753949 Lamphere Jul 2010 B2
7758595 Allen et al. Jul 2010 B2
7758632 Hojeibane et al. Jul 2010 B2
7758640 Vesely Jul 2010 B2
7771467 Svensson Aug 2010 B2
7771469 Liddicoat Aug 2010 B2
7776080 Bei et al. Aug 2010 B2
7776083 Vesely Aug 2010 B2
7780726 Seguin Aug 2010 B2
7785341 Forster et al. Aug 2010 B2
7799069 Bailey et al. Sep 2010 B2
7803181 Furst et al. Sep 2010 B2
7811296 Goldfarb et al. Oct 2010 B2
7811316 Kalmann et al. Oct 2010 B2
7824442 Salahieh et al. Nov 2010 B2
7837645 Bessler et al. Nov 2010 B2
7837727 Goetz et al. Nov 2010 B2
7842081 Yadin Nov 2010 B2
7850725 Vardi et al. Dec 2010 B2
7871432 Bergin Jan 2011 B2
7871436 Ryan et al. Jan 2011 B2
7887583 Macoviak Feb 2011 B2
7892281 Seguin et al. Feb 2011 B2
7896915 Guyenot et al. Mar 2011 B2
7914544 Nguyen et al. Mar 2011 B2
7914569 Nguyen et al. Mar 2011 B2
7927370 Webler et al. Apr 2011 B2
7942927 Kaye et al. May 2011 B2
7947072 Yang et al. May 2011 B2
7947075 Goetz et al. May 2011 B2
7955375 Agnew Jun 2011 B2
7955377 Melsheimer Jun 2011 B2
7955384 Rafiee et al. Jun 2011 B2
7959666 Salahieh et al. Jun 2011 B2
7959672 Salahieh et al. Jun 2011 B2
7967833 Sterman et al. Jun 2011 B2
7967857 Lane Jun 2011 B2
7981151 Rowe Jul 2011 B2
7981153 Fogarty et al. Jul 2011 B2
7992567 Hirotsuka et al. Aug 2011 B2
7993393 Carpentier et al. Aug 2011 B2
8002825 Letac et al. Aug 2011 B2
8002826 Seguin Aug 2011 B2
8016877 Seguin et al. Sep 2011 B2
8016882 Macoviak Sep 2011 B2
8021420 Dolan Sep 2011 B2
8021421 Fogarty et al. Sep 2011 B2
8025695 Fogarty et al. Sep 2011 B2
8029518 Goldfarb et al. Oct 2011 B2
8029557 Sobrino-Serrano et al. Oct 2011 B2
8029564 Johnson et al. Oct 2011 B2
8034104 Carpentier et al. Oct 2011 B2
8038720 Wallace et al. Oct 2011 B2
8043360 McNamara et al. Oct 2011 B2
8048138 Sulivan et al. Nov 2011 B2
8048140 Purdy Nov 2011 B2
8048153 Salahieh et al. Nov 2011 B2
8052592 Goldfarb et al. Nov 2011 B2
8052741 Bruszewski et al. Nov 2011 B2
8052749 Salahieh et al. Nov 2011 B2
8057493 Goldfarb et al. Nov 2011 B2
8057532 Hoffman Nov 2011 B2
8057540 Letac et al. Nov 2011 B2
8062355 Figulla et al. Nov 2011 B2
8062359 Marquez et al. Nov 2011 B2
8070708 Rottenberg et al. Dec 2011 B2
8070800 Lock et al. Dec 2011 B2
8070802 Lamphere et al. Dec 2011 B2
8070804 Hyde Dec 2011 B2
8075611 Milwee et al. Dec 2011 B2
8080054 Rowe Dec 2011 B2
8083793 Lane et al. Dec 2011 B2
D652927 Braido et al. Jan 2012 S
D653341 Braido et al. Jan 2012 S
8092518 Schreck Jan 2012 B2
8092520 Quadri Jan 2012 B2
8092521 Figulla et al. Jan 2012 B2
8105377 Liddicoat Jan 2012 B2
8109996 Stacchino et al. Feb 2012 B2
8118866 Herrmann et al. Feb 2012 B2
8133270 Kheradvar et al. Mar 2012 B2
8136218 Millwee et al. Mar 2012 B2
8137398 Tuval et al. Mar 2012 B2
8142492 Forster et al. Mar 2012 B2
8142494 Randert et al. Mar 2012 B2
8142496 Berreklouw Mar 2012 B2
8142497 Friedman Mar 2012 B2
8147504 Ino et al. Apr 2012 B2
8157852 Bloom et al. Apr 2012 B2
8157853 Laske et al. Apr 2012 B2
8157860 McNamara et al. Apr 2012 B2
8163008 Wilson et al. Apr 2012 B2
8163014 Lane et al. Apr 2012 B2
D660433 Braido et al. May 2012 S
D660967 Braido et al. May 2012 S
8167894 Miles et al. May 2012 B2
8167932 Bourang et al. May 2012 B2
8167935 McGuckin, Jr. et al. May 2012 B2
8172896 McNamara et al. May 2012 B2
8172898 Alferness et al. May 2012 B2
8177836 Lee et al. May 2012 B2
8182528 Salahieh et al. May 2012 B2
8211169 Lane et al. Jul 2012 B2
8216256 Raschdorf, Jr. et al. Jul 2012 B2
8216301 Bonhoeffer et al. Jul 2012 B2
8221492 Case et al. Jul 2012 B2
8221493 Boyle et al. Jul 2012 B2
8226710 Nguyen et al. Jul 2012 B2
8231670 Salahieh et al. Jul 2012 B2
8236045 Benichou et al. Aug 2012 B2
8236049 Rowe et al. Aug 2012 B2
8252042 McNamara et al. Aug 2012 B2
8252051 Chau et al. Aug 2012 B2
8252052 Salahieh et al. Aug 2012 B2
8257390 Carley et al. Sep 2012 B2
8267988 Hamer et al. Sep 2012 B2
8277501 Chalekian et al. Oct 2012 B2
8287591 Keidar et al. Oct 2012 B2
8298280 Yadin et al. Oct 2012 B2
8303653 Bonhoeffer et al. Nov 2012 B2
8308798 Pintor et al. Nov 2012 B2
8317853 Agnew Nov 2012 B2
8317855 Gregorich et al. Nov 2012 B2
8323335 Rowe et al. Dec 2012 B2
8328868 Paul et al. Dec 2012 B2
8337541 Quadri et al. Dec 2012 B2
8343174 Goldfarb et al. Jan 2013 B2
8343213 Salahieh et al. Jan 2013 B2
8348999 Kheradvar et al. Jan 2013 B2
8366767 Zhang Feb 2013 B2
8372140 Hoffman et al. Feb 2013 B2
8377119 Drews et al. Feb 2013 B2
8398708 Meiri et al. Mar 2013 B2
8403981 Forster et al. Mar 2013 B2
8403983 Quadri et al. Mar 2013 B2
8408214 Spenser Apr 2013 B2
8414644 Quadri et al. Apr 2013 B2
8425593 Braido et al. Apr 2013 B2
8430934 Das Apr 2013 B2
8444689 Zhang May 2013 B2
8449599 Chau et al. May 2013 B2
8449625 Campbell et al. May 2013 B2
8454686 Alkhatib Jun 2013 B2
8460365 Haverkost et al. Jun 2013 B2
8474460 Barrett et al. Jul 2013 B2
8500821 Sobrino-Serrano et al. Aug 2013 B2
8512400 Tran et al. Aug 2013 B2
8539662 Stacchino et al. Sep 2013 B2
8540767 Zhang Sep 2013 B2
8545544 Spenser et al. Oct 2013 B2
8551160 Figulla et al. Oct 2013 B2
8551161 Dolan Oct 2013 B2
8562672 Bonhoeffer et al. Oct 2013 B2
8568475 Nguyen et al. Oct 2013 B2
8579964 Lane et al. Nov 2013 B2
8579965 Bonhoeffer et al. Nov 2013 B2
8585755 Chau et al. Nov 2013 B2
8585756 Bonhoeffer et al. Nov 2013 B2
8591460 Wilson et al. Nov 2013 B2
8591570 Revuelta et al. Nov 2013 B2
8623075 Murray et al. Jan 2014 B2
8623080 Fogarty et al. Jan 2014 B2
8628569 Benichou et al. Jan 2014 B2
8628570 Seguin Jan 2014 B2
8628571 Hacohen et al. Jan 2014 B1
8652203 Quadri et al. Feb 2014 B2
8652204 Quill et al. Feb 2014 B2
8657872 Seguin Feb 2014 B2
8663322 Keranen Mar 2014 B2
8673020 Sobrino-Serrano et al. Mar 2014 B2
8679174 Ottma et al. Mar 2014 B2
8685086 Navia et al. Apr 2014 B2
8696742 Pintor et al. Apr 2014 B2
8728155 Montorfano et al. May 2014 B2
8734507 Keranen May 2014 B2
8747460 Tuval et al. Jun 2014 B2
8771345 Tuval et al. Jul 2014 B2
8784472 Eidenschink Jul 2014 B2
8784479 Antonsson et al. Jul 2014 B2
8784481 Alkhatib et al. Jul 2014 B2
8795355 Alkhatib Aug 2014 B2
8795356 Quadri et al. Aug 2014 B2
8795357 Yohanan et al. Aug 2014 B2
8801776 House et al. Aug 2014 B2
8808366 Braido et al. Aug 2014 B2
8840663 Salahieh et al. Sep 2014 B2
8840664 Karapetian et al. Sep 2014 B2
8845722 Gabbay Sep 2014 B2
8852261 White Oct 2014 B2
8852272 Gross et al. Oct 2014 B2
8870948 Erzberger et al. Oct 2014 B1
8870949 Rowe Oct 2014 B2
8870950 Hacohen Oct 2014 B2
8876800 Behan Nov 2014 B2
8894702 Quadri et al. Nov 2014 B2
8900294 Paniagua et al. Dec 2014 B2
8900295 Migliazza et al. Dec 2014 B2
8906083 Obermiller et al. Dec 2014 B2
8911455 Quadri et al. Dec 2014 B2
8911489 Ben-Muvhar Dec 2014 B2
8911493 Rowe et al. Dec 2014 B2
8932343 Alkhatib et al. Jan 2015 B2
8961595 Alkhatib Feb 2015 B2
8979922 Jayasinghe et al. Mar 2015 B2
8986370 Annest Mar 2015 B2
8986373 Chau et al. Mar 2015 B2
8986375 Garde et al. Mar 2015 B2
8992599 Thubrikar et al. Mar 2015 B2
8992604 Gross et al. Mar 2015 B2
8992608 Haug et al. Mar 2015 B2
8998982 Richter et al. Apr 2015 B2
9005273 Salahieh et al. Apr 2015 B2
9011527 Li et al. Apr 2015 B2
9017399 Gross et al. Apr 2015 B2
D730520 Braido et al. May 2015 S
D730521 Braido et al. May 2015 S
9023100 Quadri et al. May 2015 B2
9034032 McLean et al. May 2015 B2
9034033 McLean et al. May 2015 B2
9039757 McLean et al. May 2015 B2
D732666 Nguyen et al. Jun 2015 S
9050188 Schweich et al. Jun 2015 B2
9060858 Thornton et al. Jun 2015 B2
9072603 Tuval et al. Jul 2015 B2
9084676 Chau et al. Jul 2015 B2
9095434 Rowe Aug 2015 B2
9119719 Zipory Sep 2015 B2
9125738 Figulla et al. Sep 2015 B2
9125740 Morriss et al. Sep 2015 B2
9132006 Spenser et al. Sep 2015 B2
9132009 Hacohen et al. Sep 2015 B2
9138312 Tuval et al. Sep 2015 B2
9155619 Liu et al. Oct 2015 B2
9173659 Bodewadt et al. Nov 2015 B2
9173738 Murray et al. Nov 2015 B2
9220594 Braido et al. Dec 2015 B2
9226820 Braido et al. Jan 2016 B2
9226839 Kariniemi et al. Jan 2016 B1
9232995 Kovalsky et al. Jan 2016 B2
9241790 Lane et al. Jan 2016 B2
9241791 Braido et al. Jan 2016 B2
9241792 Benichou et al. Jan 2016 B2
9241794 Braido et al. Jan 2016 B2
9248014 Lane et al. Feb 2016 B2
9277994 Miller Mar 2016 B2
9289290 Alkhatib et al. Mar 2016 B2
9289291 Gorman et al. Mar 2016 B2
9295550 Nguyen et al. Mar 2016 B2
9295551 Straubinger Mar 2016 B2
9295552 McLean et al. Mar 2016 B2
9301836 Buchbinder et al. Apr 2016 B2
9320591 Bolduc Apr 2016 B2
D755384 Pesce et al. May 2016 S
9326852 Spenser May 2016 B2
9326876 Acosta et al. May 2016 B2
9345573 Nyuli et al. May 2016 B2
9387078 Gross et al. Jul 2016 B2
9393110 Levi Jul 2016 B2
9421098 Gifford et al. Aug 2016 B2
9427303 Liddy et al. Aug 2016 B2
9427316 Schweich, Jr. et al. Aug 2016 B2
9439757 Wallace et al. Sep 2016 B2
9463102 Kelly Oct 2016 B2
9474638 Robinson et al. Oct 2016 B2
9480559 Vidlund et al. Nov 2016 B2
9492273 Wallace et al. Nov 2016 B2
9498314 Behan Nov 2016 B2
9498332 Hacohen et al. Nov 2016 B2
9510947 Straubinger et al. Dec 2016 B2
9532870 Cooper et al. Jan 2017 B2
9554897 Lane et al. Jan 2017 B2
9554899 Granada et al. Jan 2017 B2
9561103 Granada et al. Feb 2017 B2
9566152 Schweich et al. Feb 2017 B2
9597182 Straubinger Mar 2017 B2
9629716 Seguin Apr 2017 B2
9662203 Sheahan et al. May 2017 B2
9681952 Hacohen et al. Jun 2017 B2
9717591 Chau et al. Aug 2017 B2
9743932 Amplatz et al. Aug 2017 B2
9763657 Hacohen et al. Sep 2017 B2
9763817 Roeder Sep 2017 B2
9770256 Cohen et al. Sep 2017 B2
D800908 Hariton et al. Oct 2017 S
9788941 Hacohen Oct 2017 B2
9895226 Harari et al. Feb 2018 B1
9987132 Hariton et al. Jun 2018 B1
10010414 Cooper et al. Jul 2018 B2
10076415 Metchik et al. Sep 2018 B1
10105222 Metchik et al. Oct 2018 B1
10111751 Metchik et al. Oct 2018 B1
10123873 Metchik et al. Nov 2018 B1
10130475 Metchik et al. Nov 2018 B1
10136993 Metchik et al. Nov 2018 B1
10143552 Wallace et al. Dec 2018 B2
10149761 Granada et al. Dec 2018 B2
10154903 Albitov et al. Dec 2018 B2
10154906 Granada et al. Dec 2018 B2
10159570 Metchik et al. Dec 2018 B1
10182908 Tubishevitz et al. Jan 2019 B2
10226341 Gross et al. Mar 2019 B2
10231837 Metchik et al. Mar 2019 B1
10238493 Metchik et al. Mar 2019 B1
10245143 Gross et al. Apr 2019 B2
10245144 Metchik et al. Apr 2019 B1
10258471 Lutter et al. Apr 2019 B2
10299927 McLean May 2019 B2
10321995 Christianson et al. Jun 2019 B1
10322020 Lam et al. Jun 2019 B2
10327895 Lozonschi et al. Jun 2019 B2
10335278 McLean Jul 2019 B2
10376361 Gross et al. Aug 2019 B2
10426614 Hariton et al. Oct 2019 B2
10507108 Delgado et al. Dec 2019 B2
10507109 Metchik et al. Dec 2019 B2
10512456 Hacohen Dec 2019 B2
10517719 Miller Dec 2019 B2
10524792 Hernandez et al. Jan 2020 B2
10531866 Hariton et al. Jan 2020 B2
10531872 Hacohen et al. Jan 2020 B2
10548731 Lashinski et al. Feb 2020 B2
10575948 Iamberger et al. Mar 2020 B2
10595992 Chambers Mar 2020 B2
10595997 Metchik et al. Mar 2020 B2
10610358 Vidlund Apr 2020 B2
10646342 Marr et al. May 2020 B1
10702385 Hacohen Jul 2020 B2
10758342 Chau Sep 2020 B2
10813760 Metchik et al. Oct 2020 B2
10820998 Marr et al. Nov 2020 B2
10842627 Delgado Nov 2020 B2
10856975 Hariton Dec 2020 B2
10856978 Straubinger Dec 2020 B2
10874514 Dixon Dec 2020 B2
10888644 Ratz Jan 2021 B2
10905552 Dixon Feb 2021 B2
10905554 Cao Feb 2021 B2
10918483 Metchik Feb 2021 B2
10945844 Mccann Mar 2021 B2
10993809 Mccann May 2021 B2
11083582 Mccann Aug 2021 B2
11147672 Mccann Oct 2021 B2
20010002445 Vesely May 2001 A1
20010005787 Oz Jun 2001 A1
20010021872 Bailey et al. Sep 2001 A1
20010056295 Solem Dec 2001 A1
20020013571 Goldfarb et al. Jan 2002 A1
20020032481 Gabbay Mar 2002 A1
20020099436 Thornton et al. Jul 2002 A1
20020151970 Garrison et al. Oct 2002 A1
20020177894 Acosta et al. Nov 2002 A1
20030036791 Bonhoeffer et al. Feb 2003 A1
20030050694 Yang Mar 2003 A1
20030060875 Wittens Mar 2003 A1
20030069635 Cartledge Apr 2003 A1
20030074052 Besselink Apr 2003 A1
20030083742 Spence et al. May 2003 A1
20030105519 Fasol et al. Jun 2003 A1
20030158578 Pantages et al. Aug 2003 A1
20040010272 Manetakis et al. Jan 2004 A1
20040030382 St. Goar et al. Feb 2004 A1
20040039414 Carley et al. Feb 2004 A1
20040093060 Seguin et al. May 2004 A1
20040122503 Campbell et al. Jun 2004 A1
20040122514 Fogarty et al. Jun 2004 A1
20040133267 Lane Jul 2004 A1
20040143315 Bruun et al. Jul 2004 A1
20040176839 Huynh et al. Sep 2004 A1
20040186558 Pavcnik et al. Sep 2004 A1
20040186565 Schreck Sep 2004 A1
20040186566 Hindrichs et al. Sep 2004 A1
20040210244 Vargas et al. Oct 2004 A1
20040210304 Seguin et al. Oct 2004 A1
20040220593 Greenhalgh Nov 2004 A1
20040225354 Allen et al. Nov 2004 A1
20040236354 Seguin Nov 2004 A1
20040249433 Freitag Dec 2004 A1
20040260389 Case et al. Dec 2004 A1
20040260394 Douk et al. Dec 2004 A1
20050004668 Aklog et al. Jan 2005 A1
20050021056 St. Goar et al. Jan 2005 A1
20050027305 Shiu et al. Feb 2005 A1
20050027348 Case et al. Feb 2005 A1
20050038494 Eidenschink Feb 2005 A1
20050055086 Stobie Mar 2005 A1
20050075731 Artof et al. Apr 2005 A1
20050080430 Wright et al. Apr 2005 A1
20050080474 Andreas Apr 2005 A1
20050085900 Case et al. Apr 2005 A1
20050137686 Salahieh et al. Jun 2005 A1
20050137688 Salahieh et al. Jun 2005 A1
20050137689 Salahieh et al. Jun 2005 A1
20050137690 Salahieh et al. Jun 2005 A1
20050137691 Salahieh Jun 2005 A1
20050137692 Haug et al. Jun 2005 A1
20050137695 Salahieh et al. Jun 2005 A1
20050137697 Salahieh et al. Jun 2005 A1
20050143809 Salahieh et al. Jun 2005 A1
20050149160 McFerran Jul 2005 A1
20050154443 Linder et al. Jul 2005 A1
20050182483 Osborne et al. Aug 2005 A1
20050182486 Gabbay Aug 2005 A1
20050197695 Stacchino et al. Sep 2005 A1
20050203549 Realyvasquez Sep 2005 A1
20050203618 Sharkawy et al. Sep 2005 A1
20050216079 MaCoviak Sep 2005 A1
20050234508 Cummins et al. Oct 2005 A1
20050240200 Bergheim Oct 2005 A1
20050251251 Cribier Nov 2005 A1
20050256566 Gabbay Nov 2005 A1
20050267573 Macoviak et al. Dec 2005 A9
20060004439 Spenser et al. Jan 2006 A1
20060004469 Sokel Jan 2006 A1
20060015171 Armstrong Jan 2006 A1
20060020275 Goldfarb et al. Jan 2006 A1
20060020327 Lashinski et al. Jan 2006 A1
20060020333 Lashinski et al. Jan 2006 A1
20060041189 Vancaillie Feb 2006 A1
20060052867 Revuelta et al. Mar 2006 A1
20060089627 Burnett et al. Apr 2006 A1
20060111773 Rittgers et al. May 2006 A1
20060116750 Herbert et al. Jun 2006 A1
20060135964 Vesley Jun 2006 A1
20060155357 Melsheimer Jul 2006 A1
20060161250 Shaw Jul 2006 A1
20060047297 Case Aug 2006 A1
20060178700 Quinn Aug 2006 A1
20060178740 Stacchino et al. Aug 2006 A1
20060184203 Martin et al. Aug 2006 A1
20060190036 Wendel et al. Aug 2006 A1
20060190038 Carley et al. Aug 2006 A1
20060195183 Navia et al. Aug 2006 A1
20060195184 Lane et al. Aug 2006 A1
20060201519 Frazier et al. Sep 2006 A1
20060212111 Case et al. Sep 2006 A1
20060216404 Seyler Sep 2006 A1
20060229708 Powell et al. Oct 2006 A1
20060241656 Starksen et al. Oct 2006 A1
20060241745 Solem Oct 2006 A1
20060241748 Lee et al. Oct 2006 A1
20060247680 Amplatz et al. Nov 2006 A1
20060253191 Salahieh et al. Nov 2006 A1
20060259136 Nguyen et al. Nov 2006 A1
20060259137 Artof et al. Nov 2006 A1
20060271166 Thill et al. Nov 2006 A1
20060271171 McQuinn et al. Nov 2006 A1
20060282150 Olson et al. Dec 2006 A1
20060287719 Rowe et al. Dec 2006 A1
20070016286 Herrmann Jan 2007 A1
20070016288 Gurskis et al. Jan 2007 A1
20070027528 Agnew Feb 2007 A1
20070027549 Godin Feb 2007 A1
20070038293 St. Goar et al. Feb 2007 A1
20070038295 Case et al. Feb 2007 A1
20070043435 Seguin et al. Feb 2007 A1
20070055340 Pryor Mar 2007 A1
20070056346 Spenser et al. Mar 2007 A1
20070078510 Ryan Apr 2007 A1
20070112422 Dehdashtian May 2007 A1
20070118151 Davidson May 2007 A1
20070162103 Case et al. Jul 2007 A1
20070162107 Haug et al. Jul 2007 A1
20070162111 Fukamachi et al. Jul 2007 A1
20070173932 Cali et al. Jul 2007 A1
20070197858 Goldfarb et al. Aug 2007 A1
20070198077 Cully et al. Aug 2007 A1
20070198097 Zegdi Aug 2007 A1
20070213810 Newhauser et al. Sep 2007 A1
20070213813 Von Segesser et al. Sep 2007 A1
20070219630 Chu Sep 2007 A1
20070225759 Thommen et al. Sep 2007 A1
20070225760 Moszner et al. Sep 2007 A1
20070233186 Meng Oct 2007 A1
20070233237 Krivoruchko Oct 2007 A1
20070239272 Navia et al. Oct 2007 A1
20070239273 Allen Oct 2007 A1
20070244546 Francis Oct 2007 A1
20070255400 Parravicini et al. Nov 2007 A1
20080004688 Spenser et al. Jan 2008 A1
20080004697 Lichtenstein et al. Jan 2008 A1
20080051703 Thornton et al. Feb 2008 A1
20080071361 Tuval et al. Mar 2008 A1
20080071363 Tuval et al. Mar 2008 A1
20080071366 Tuval et al. Mar 2008 A1
20080071369 Tuval et al. Mar 2008 A1
20080077235 Kirson Mar 2008 A1
20080082083 Forde et al. Apr 2008 A1
20080082159 Tseng et al. Apr 2008 A1
20080082166 Styrc et al. Apr 2008 A1
20080086164 Rowe et al. Apr 2008 A1
20080086204 Rankin Apr 2008 A1
20080091261 Long et al. Apr 2008 A1
20080097595 Gabbay Apr 2008 A1
20080132989 Snow et al. Jun 2008 A1
20080140003 Bei et al. Jun 2008 A1
20080147182 Righini et al. Jun 2008 A1
20080161910 Revuelta et al. Jul 2008 A1
20080167705 Agnew Jul 2008 A1
20080167714 St. Goar et al. Jul 2008 A1
20080188929 Schreck Aug 2008 A1
20080195200 Vidlund et al. Aug 2008 A1
20080200980 Robin et al. Aug 2008 A1
20080208328 Antocci Aug 2008 A1
20080208332 Lamphere et al. Aug 2008 A1
20080221672 Lamphere et al. Sep 2008 A1
20080234814 Salahieh et al. Sep 2008 A1
20080243245 Thambar et al. Oct 2008 A1
20080255580 Hoffman et al. Oct 2008 A1
20080262609 Gross et al. Oct 2008 A1
20080269879 Sathe et al. Oct 2008 A1
20080281411 Berreklouw Nov 2008 A1
20080294234 Hartley et al. Nov 2008 A1
20090005863 Goetz et al. Jan 2009 A1
20090036966 O'Connor et al. Feb 2009 A1
20090054969 Salahieh et al. Feb 2009 A1
20090088836 Bishop et al. Apr 2009 A1
20090099554 Forster et al. Apr 2009 A1
20090099650 Bolduc et al. Apr 2009 A1
20090112159 Slattery et al. Apr 2009 A1
20090125098 Chuter May 2009 A1
20090157175 Benichou Jun 2009 A1
20090171363 Chocron Jul 2009 A1
20090177278 Spence Jul 2009 A1
20090210052 Forster et al. Aug 2009 A1
20090222081 Linder et al. Sep 2009 A1
20090240320 Tuval et al. Sep 2009 A1
20090248143 Laham Oct 2009 A1
20090259306 Rowe Oct 2009 A1
20090264859 Mas Oct 2009 A1
20090264994 Saadat Oct 2009 A1
20090276040 Rowe et al. Nov 2009 A1
20090281619 Le et al. Nov 2009 A1
20090287304 Dahlgren et al. Nov 2009 A1
20090299449 Styrc Dec 2009 A1
20090306768 Quardi Dec 2009 A1
20090319037 Rowe et al. Dec 2009 A1
20100022823 Goldfarb Jan 2010 A1
20100023117 Yoganathan et al. Jan 2010 A1
20100023120 Holecek et al. Jan 2010 A1
20100036479 Hill et al. Feb 2010 A1
20100049313 Alon et al. Feb 2010 A1
20100069852 Kelley Mar 2010 A1
20100076548 Konno Mar 2010 A1
20100100167 Bortlein Apr 2010 A1
20100114299 Ben Muvhar et al. May 2010 A1
20100131054 Tuval et al. May 2010 A1
20100137979 Tuval et al. Jun 2010 A1
20100160958 Clark Jun 2010 A1
20100161036 Pintor et al. Jun 2010 A1
20100161042 Maisano et al. Jun 2010 A1
20100174363 Castro Jul 2010 A1
20100179643 Shalev Jul 2010 A1
20100179648 Richter et al. Jul 2010 A1
20100179649 Richter et al. Jul 2010 A1
20100217382 Chau et al. Aug 2010 A1
20100222810 DeBeer et al. Sep 2010 A1
20100228285 Miles et al. Sep 2010 A1
20100234940 Dolan Sep 2010 A1
20100249908 Chau et al. Sep 2010 A1
20100249917 Zhang Sep 2010 A1
20100256737 Pollock et al. Oct 2010 A1
20100262232 Annest Oct 2010 A1
20100280603 Maisano et al. Nov 2010 A1
20100280606 Naor Nov 2010 A1
20100312333 Navia et al. Dec 2010 A1
20100324595 Linder et al. Dec 2010 A1
20100331971 Keränen et al. Dec 2010 A1
20110004227 Goldfarb et al. Jan 2011 A1
20110004296 Lutter et al. Jan 2011 A1
20110004299 Navia et al. Jan 2011 A1
20110015729 Jimenez et al. Jan 2011 A1
20110015731 Carpentier et al. Jan 2011 A1
20110021985 Spargias Jan 2011 A1
20110022165 Oba et al. Jan 2011 A1
20110178597 Navia et al. Jan 2011 A9
20110029072 Gabbay Feb 2011 A1
20110040374 Goetz et al. Feb 2011 A1
20110040375 Letac et al. Feb 2011 A1
20110046662 Moszner et al. Feb 2011 A1
20110054466 Rothstein et al. Mar 2011 A1
20110054596 Taylor Mar 2011 A1
20110054598 Johnson Mar 2011 A1
20110066233 Thornton et al. Mar 2011 A1
20110071626 Wright et al. Mar 2011 A1
20110077730 Fentster Mar 2011 A1
20110082538 Dahlgren et al. Apr 2011 A1
20110087322 Letac et al. Apr 2011 A1
20110093063 Schreck Apr 2011 A1
20110098525 Kermode et al. Apr 2011 A1
20110106247 Miller et al. May 2011 A1
20110112625 Ben-Muvhar et al. May 2011 A1
20110112632 Chau et al. May 2011 A1
20110113768 Bauer et al. May 2011 A1
20110118830 Liddicoat et al. May 2011 A1
20110125257 Seguin et al. May 2011 A1
20110125258 Centola May 2011 A1
20110137326 Bachman Jun 2011 A1
20110137397 Chau et al. Jun 2011 A1
20110137409 Yang et al. Jun 2011 A1
20110137410 Hacohen Jun 2011 A1
20110144742 Madrid et al. Jun 2011 A1
20110166636 Rowe Jul 2011 A1
20110172784 Richter Jul 2011 A1
20110184510 Maisano et al. Jul 2011 A1
20110190877 Lane et al. Aug 2011 A1
20110190879 Bobo et al. Aug 2011 A1
20110202076 Richter Aug 2011 A1
20110208283 Rust Aug 2011 A1
20110208293 Tabor Aug 2011 A1
20110208298 Tuval et al. Aug 2011 A1
20110213459 Garrison et al. Sep 2011 A1
20110213461 Seguin et al. Sep 2011 A1
20110218619 Benichou et al. Sep 2011 A1
20110218620 Meiri et al. Sep 2011 A1
20110224785 Hacohen Sep 2011 A1
20110238159 Guyenot et al. Sep 2011 A1
20110245911 Quill et al. Oct 2011 A1
20110245917 Savage et al. Oct 2011 A1
20110251675 Dwork Oct 2011 A1
20110251676 Sweeney et al. Oct 2011 A1
20110251678 Eidenschink et al. Oct 2011 A1
20110251679 Wiemeyer et al. Oct 2011 A1
20110251680 Tran et al. Oct 2011 A1
20110251682 Murray, III et al. Oct 2011 A1
20110251683 Tabor Oct 2011 A1
20110257721 Tabor Oct 2011 A1
20110257729 Spenser et al. Oct 2011 A1
20110257736 Marquez et al. Oct 2011 A1
20110257737 Fogarty et al. Oct 2011 A1
20110264191 Rothstein Oct 2011 A1
20110264196 Savage et al. Oct 2011 A1
20110264198 Murray, III et al. Oct 2011 A1
20110264199 Tran et al. Oct 2011 A1
20110264200 Tran et al. Oct 2011 A1
20110264201 Yeung et al. Oct 2011 A1
20110264202 Murray, III et al. Oct 2011 A1
20110264203 Dwork et al. Oct 2011 A1
20110264206 Tabor Oct 2011 A1
20110264208 Duffy Oct 2011 A1
20110270276 Rothstein et al. Nov 2011 A1
20110271967 Mortier et al. Nov 2011 A1
20110282438 Drews et al. Nov 2011 A1
20110282439 Thill et al. Nov 2011 A1
20110282440 Cao Nov 2011 A1
20110283514 Fogarty et al. Nov 2011 A1
20110288632 White Nov 2011 A1
20110288634 Tuval et al. Nov 2011 A1
20110295354 Bueche et al. Dec 2011 A1
20110295363 Girard et al. Dec 2011 A1
20110301688 Dolan Dec 2011 A1
20110301698 Miller et al. Dec 2011 A1
20110301701 Padala et al. Dec 2011 A1
20110301702 Rust et al. Dec 2011 A1
20110306916 Nitzan et al. Dec 2011 A1
20110307049 Kao Dec 2011 A1
20110313452 Carley et al. Dec 2011 A1
20110313515 Quadri et al. Dec 2011 A1
20110319989 Lane et al. Dec 2011 A1
20110319991 Hariton et al. Dec 2011 A1
20120010694 Lutter et al. Jan 2012 A1
20120016468 Robin et al. Jan 2012 A1
20120022629 Perera et al. Jan 2012 A1
20120022633 Olson et al. Jan 2012 A1
20120022637 Ben-Muvhar et al. Jan 2012 A1
20120022639 Hacohen et al. Jan 2012 A1
20120022640 Gross et al. Jan 2012 A1
20120035703 Lutter et al. Feb 2012 A1
20120035713 Lutter et al. Feb 2012 A1
20120035722 Tuval et al. Feb 2012 A1
20120041547 Duffy et al. Feb 2012 A1
20120041551 Spenser et al. Feb 2012 A1
20120046738 Lau et al. Feb 2012 A1
20120046742 Tuval et al. Feb 2012 A1
20120053676 Ku et al. Mar 2012 A1
20120053682 Kovalsky et al. Mar 2012 A1
20120053688 Fogarty et al. Mar 2012 A1
20120059337 Eilat Mar 2012 A1
20120059454 Millwee et al. Mar 2012 A1
20120059458 Buchbinder et al. Mar 2012 A1
20120065464 Ellis et al. Mar 2012 A1
20120078237 Wang et al. Mar 2012 A1
20120078353 Quadri et al. Mar 2012 A1
20120078357 Conklin Mar 2012 A1
20120083832 Delaloye et al. Apr 2012 A1
20120083839 Letac et al. Apr 2012 A1
20120083879 Eberhardt et al. Apr 2012 A1
20120089223 Nguyen et al. Apr 2012 A1
20120101570 Tuval et al. Apr 2012 A1
20120101571 Thambar et al. Apr 2012 A1
20120101572 Kovalsky et al. Apr 2012 A1
20120123511 Brown May 2012 A1
20120123530 Carpentier et al. May 2012 A1
20120130473 Norris et al. May 2012 A1
20120130474 Buckley May 2012 A1
20120130475 Shaw May 2012 A1
20120136434 Carpentier et al. May 2012 A1
20120150218 Sandgren et al. Jun 2012 A1
20120165915 Melsheimer et al. Jun 2012 A1
20120165930 Gifford, III Jun 2012 A1
20120179244 Schankereli et al. Jul 2012 A1
20120197292 Chin-Chen et al. Aug 2012 A1
20120283824 Lutter et al. Nov 2012 A1
20120290062 McNamara et al. Nov 2012 A1
20120296360 Norris et al. Nov 2012 A1
20120296418 Bonyuet et al. Nov 2012 A1
20120300063 Majkrzak et al. Nov 2012 A1
20120310328 Olson et al. Dec 2012 A1
20120323316 Chau et al. Dec 2012 A1
20120330408 Hillukka et al. Dec 2012 A1
20130006347 McHugo Jan 2013 A1
20130018450 Hunt Jan 2013 A1
20130018458 Yohanan et al. Jan 2013 A1
20130035759 Gross et al. Feb 2013 A1
20130041204 Heilman et al. Feb 2013 A1
20130041451 Patterson et al. Feb 2013 A1
20130046373 Cartledge et al. Feb 2013 A1
20130066342 Dell Mar 2013 A1
20130079872 Gallagher Mar 2013 A1
20130116780 Miller et al. May 2013 A1
20130123896 Bloss et al. May 2013 A1
20130123900 Eblacas et al. May 2013 A1
20130150945 Crawford et al. Jun 2013 A1
20130150956 Yohanan et al. Jun 2013 A1
20130158647 Norris et al. Jun 2013 A1
20130166017 Cartledge et al. Jun 2013 A1
20130166022 Conklin Jun 2013 A1
20130172978 Vidlund et al. Jul 2013 A1
20130172992 Gross et al. Jul 2013 A1
20130178930 Straubinger Jul 2013 A1
20130190861 Chau et al. Jul 2013 A1
20130211501 Buckley et al. Aug 2013 A1
20130231735 Deem et al. Sep 2013 A1
20130245742 Norris Sep 2013 A1
20130253634 Wilson Sep 2013 A1
20130253643 Rolando Sep 2013 A1
20130261737 Costello Oct 2013 A1
20130261738 Clague et al. Oct 2013 A1
20130274870 Lombardi et al. Oct 2013 A1
20130282059 Ketai et al. Oct 2013 A1
20130289711 Liddy et al. Oct 2013 A1
20130289740 Liddy et al. Oct 2013 A1
20130297013 Klima et al. Nov 2013 A1
20130304197 Buchbinder et al. Nov 2013 A1
20130304200 McLean et al. Nov 2013 A1
20130310928 Morriss et al. Nov 2013 A1
20130325114 McLean et al. Dec 2013 A1
20130331929 Mitra et al. Dec 2013 A1
20140000112 Braido et al. Jan 2014 A1
20140005778 Buchbinder et al. Jan 2014 A1
20140018911 Zhou et al. Jan 2014 A1
20140018915 Biadillah et al. Jan 2014 A1
20140031928 Murphy et al. Jan 2014 A1
20140046430 Shaw Feb 2014 A1
20140052237 Lane et al. Feb 2014 A1
20140067050 Costello et al. Mar 2014 A1
20140067054 Chau et al. Mar 2014 A1
20140081376 Burkart et al. Mar 2014 A1
20140106951 Brandon Apr 2014 A1
20140120287 Jacoby et al. May 2014 A1
20140121749 Roeder May 2014 A1
20140121763 Duffy et al. May 2014 A1
20140135894 Norris et al. May 2014 A1
20140135895 Andress et al. May 2014 A1
20140142681 Norris May 2014 A1
20140142688 Duffy et al. May 2014 A1
20140148891 Johnson May 2014 A1
20140163690 White Jun 2014 A1
20140172069 Roeder et al. Jun 2014 A1
20140172077 Bruchman et al. Jun 2014 A1
20140172082 Bruchman et al. Jun 2014 A1
20140188210 Beard et al. Jul 2014 A1
20140188221 Chung et al. Jul 2014 A1
20140194981 Menk et al. Jul 2014 A1
20140194983 Kovalsky et al. Jul 2014 A1
20140207231 Hacohen et al. Jul 2014 A1
20140214159 Vidlund et al. Jul 2014 A1
20140222136 Geist et al. Aug 2014 A1
20140222142 Kovalsky et al. Aug 2014 A1
20140236287 Clague et al. Aug 2014 A1
20140236289 Alkhatib Aug 2014 A1
20140249622 Carmi et al. Sep 2014 A1
20140257461 Robinson et al. Sep 2014 A1
20140257467 Lane et al. Sep 2014 A1
20140257475 Gross et al. Sep 2014 A1
20140257476 Montorfano et al. Sep 2014 A1
20140277358 Slazas Sep 2014 A1
20140277409 Börtlein et al. Sep 2014 A1
20140277411 Börtlein et al. Sep 2014 A1
20140277418 Miller Sep 2014 A1
20140277422 Ratz et al. Sep 2014 A1
20140277427 Ratz et al. Sep 2014 A1
20140296962 Cartledge et al. Oct 2014 A1
20140296969 Tegels et al. Oct 2014 A1
20140324164 Gross et al. Oct 2014 A1
20140336744 Tani et al. Nov 2014 A1
20140343670 Bakis et al. Nov 2014 A1
20140358222 Gorman, III et al. Dec 2014 A1
20140358224 Tegels et al. Dec 2014 A1
20140379065 Johnson et al. Dec 2014 A1
20140379074 Spence et al. Dec 2014 A1
20140379076 Vidlund et al. Dec 2014 A1
20150018944 O'Connor et al. Jan 2015 A1
20150032205 Matheny Jan 2015 A1
20150045880 Hacohen Feb 2015 A1
20150045881 Lim Feb 2015 A1
20150094802 Buchbinder et al. Apr 2015 A1
20150119970 Nakayama et al. Apr 2015 A1
20150127097 Neumann et al. May 2015 A1
20150142100 Morriss et al. May 2015 A1
20150142103 Vidlund May 2015 A1
20150148894 Damm et al. May 2015 A1
20150157457 Hacohen Jun 2015 A1
20150157458 Thambar et al. Jun 2015 A1
20150173896 Richter et al. Jun 2015 A1
20150173897 Raanani Jun 2015 A1
20150196390 Ma Jul 2015 A1
20150196393 Vidlund et al. Jul 2015 A1
20150216661 Hacohen et al. Aug 2015 A1
20150238313 Spence et al. Aug 2015 A1
20150245934 Lombardi et al. Sep 2015 A1
20150250588 Yang Sep 2015 A1
20150272730 Melnick et al. Oct 2015 A1
20150272731 Racchini Oct 2015 A1
20150272734 Sheps et al. Oct 2015 A1
20150282964 Beard et al. Oct 2015 A1
20150320556 Levi et al. Nov 2015 A1
20150327994 Morriss et al. Nov 2015 A1
20150328000 Ratz et al. Nov 2015 A1
20150335429 Morriss et al. Nov 2015 A1
20150342736 Rabito et al. Dec 2015 A1
20150351903 Morriss et al. Dec 2015 A1
20150351904 Cooper et al. Dec 2015 A1
20150351906 Hammer et al. Dec 2015 A1
20150359629 Ganesan et al. Dec 2015 A1
20160030169 Shahriari Feb 2016 A1
20160030171 Quijano et al. Feb 2016 A1
20160089482 Siegenthaler Mar 2016 A1
20160095700 Righini Apr 2016 A1
20160100939 Armstrong et al. Apr 2016 A1
20160106539 Buchbinder et al. Apr 2016 A1
20160113766 Ganesan et al. Apr 2016 A1
20160113768 Ganesan et al. Apr 2016 A1
20160125160 Heneghan et al. May 2016 A1
20160175095 Dienno et al. Jun 2016 A1
20160213473 Hacohen et al. Jul 2016 A1
20160220367 Barrett Aug 2016 A1
20160228247 Maimon et al. Aug 2016 A1
20160242902 Morriss et al. Aug 2016 A1
20160270911 Ganesan et al. Sep 2016 A1
20160296330 Hacohen Oct 2016 A1
20160310268 Oba Oct 2016 A1
20160310274 Gross et al. Oct 2016 A1
20160317301 Quadri et al. Nov 2016 A1
20160317305 Pelled et al. Nov 2016 A1
20160324633 Gross et al. Nov 2016 A1
20160324635 Vidlund et al. Nov 2016 A1
20160324640 Gifford et al. Nov 2016 A1
20160331526 Schweich et al. Nov 2016 A1
20160331527 Vidlund et al. Nov 2016 A1
20160338706 Rowe Nov 2016 A1
20160367360 Cartledge et al. Dec 2016 A1
20160367368 Vidlund et al. Dec 2016 A1
20160374801 Jimenez et al. Dec 2016 A1
20160374802 Levi et al. Dec 2016 A1
20170042678 Ganesan et al. Feb 2017 A1
20170049435 Sauer Feb 2017 A1
20170056166 Ratz et al. Mar 2017 A1
20170056171 Cooper et al. Mar 2017 A1
20170065407 Hacohen et al. Mar 2017 A1
20170065411 Grundeman et al. Mar 2017 A1
20170128205 Tamir et al. May 2017 A1
20170135816 Lashinski et al. May 2017 A1
20170189174 Braido et al. Jul 2017 A1
20170196688 Christianson et al. Jul 2017 A1
20170196692 Kirk et al. Jul 2017 A1
20170209264 Chau et al. Jul 2017 A1
20170216026 Quill et al. Aug 2017 A1
20170224323 Rowe et al. Aug 2017 A1
20170231757 Gassler Aug 2017 A1
20170231759 Geist et al. Aug 2017 A1
20170231760 Lane et al. Aug 2017 A1
20170239048 Goldfarb et al. Aug 2017 A1
20170333183 Backus Nov 2017 A1
20170333187 Hariton et al. Nov 2017 A1
20180000580 Wallace et al. Jan 2018 A1
20180021129 Peterson et al. Jan 2018 A1
20180028215 Cohen Feb 2018 A1
20180049873 Manash et al. Feb 2018 A1
20180055628 Patel et al. Mar 2018 A1
20180055630 Patel et al. Mar 2018 A1
20180098850 Rafiee Apr 2018 A1
20180116843 Schreck May 2018 A1
20180125644 Conklin May 2018 A1
20180153687 Hariton et al. Jun 2018 A1
20180153689 Maimon et al. Jun 2018 A1
20180153696 Albitov et al. Jun 2018 A1
20180177593 Hariton et al. Jun 2018 A1
20180177594 Patel et al. Jun 2018 A1
20180185148 Hariton et al. Jul 2018 A1
20180206983 Noe et al. Jul 2018 A1
20180214263 Rolando et al. Aug 2018 A1
20180250126 O'connor et al. Sep 2018 A1
20180250147 Syed Sep 2018 A1
20180296336 Cooper et al. Oct 2018 A1
20180296341 Noe et al. Oct 2018 A1
20180344457 Gross et al. Dec 2018 A1
20180353294 Calomeni et al. Dec 2018 A1
20180360457 Ellis et al. Dec 2018 A1
20190053896 Adamek-bowers et al. Feb 2019 A1
20190060060 Chau et al. Feb 2019 A1
20190060068 Cope et al. Feb 2019 A1
20190060070 Groothuis et al. Feb 2019 A1
20190069997 Ratz et al. Mar 2019 A1
20190105153 Barash et al. Apr 2019 A1
20190117391 Humair Apr 2019 A1
20190167423 Hariton et al. Jun 2019 A1
20190175339 Vidlund Jun 2019 A1
20190183639 Moore Jun 2019 A1
20190192295 Spence Jun 2019 A1
20190216602 Lozonschi Jul 2019 A1
20190231525 Hariton et al. Aug 2019 A1
20190336280 Naor Nov 2019 A1
20190350701 Adamek-bowers et al. Nov 2019 A1
20190365530 Hoang et al. Dec 2019 A1
20190388218 Vidlund et al. Dec 2019 A1
20190388220 Vidlund et al. Dec 2019 A1
20200000449 Goldfarb et al. Jan 2020 A1
20200000579 Manash et al. Jan 2020 A1
20200015964 Noe et al. Jan 2020 A1
20200030098 Delgado et al. Jan 2020 A1
20200054335 Hernandez et al. Feb 2020 A1
20200060818 Geist et al. Feb 2020 A1
20200113677 McCann et al. Apr 2020 A1
20200113689 McCann et al. Apr 2020 A1
20200113692 McCann et al. Apr 2020 A1
20200138567 Marr et al. May 2020 A1
20200163761 Hariton et al. May 2020 A1
20200214832 Metchik et al. Jul 2020 A1
20200237512 McCann et al. Jul 2020 A1
20200246136 Marr et al. Aug 2020 A1
20200246140 Hariton et al. Aug 2020 A1
20200253600 Darabian Aug 2020 A1
20200261094 Goldfarb et al. Aug 2020 A1
20200315786 Metchik et al. Oct 2020 A1
20200337842 Metchik et al. Oct 2020 A1
20210093449 Hariton et al. Apr 2021 A1
20210113331 Quadri Apr 2021 A1
Foreign Referenced Citations (107)
Number Date Country
2822801 Aug 2006 CA
103974674 Aug 2014 CN
0170262 Feb 1986 EP
1264582 Dec 2002 EP
1637092 Mar 2006 EP
1768630 Jan 2015 EP
2349124 Oct 2018 EP
3583922 Dec 2019 EP
3270825 Apr 2020 EP
2485795 Sep 2020 EP
S53152790 Dec 1978 JP
20010046894 Jun 2001 KR
1998043557 Oct 1998 WO
1999030647 Jun 1999 WO
2000-047139 Aug 2000 WO
2001-062189 Aug 2001 WO
0182832 Nov 2001 WO
2003020179 Mar 2003 WO
2003028558 Apr 2003 WO
2004028399 Apr 2004 WO
2004108191 Dec 2004 WO
2005107650 Nov 2005 WO
2006007401 Jan 2006 WO
2006007389 Jan 2006 WO
06054930 May 2006 WO
2006070372 Jul 2006 WO
2006086434 Aug 2006 WO
2006089236 Aug 2006 WO
2006116558 Nov 2006 WO
2006128193 Nov 2006 WO
2007047488 Apr 2007 WO
2007059252 May 2007 WO
08013915 Jan 2008 WO
2008029296 Mar 2008 WO
2008031103 Mar 2008 WO
2008070797 Jun 2008 WO
2008103722 Aug 2008 WO
09033469 Mar 2009 WO
09053497 Apr 2009 WO
2009091509 Jul 2009 WO
2010006627 Jan 2010 WO
2010027485 Mar 2010 WO
2010037141 Apr 2010 WO
2010045297 Apr 2010 WO
2010057262 May 2010 WO
2010073246 Jul 2010 WO
2010081033 Jul 2010 WO
2010121076 Oct 2010 WO
2011025972 Mar 2011 WO
2011069048 Jun 2011 WO
2011089601 Jul 2011 WO
2011106137 Sep 2011 WO
2011111047 Sep 2011 WO
0187190 Nov 2011 WO
2011137531 Nov 2011 WO
2011-143263 Nov 2011 WO
2011144351 Nov 2011 WO
2011154942 Dec 2011 WO
2012011108 Jan 2012 WO
2012024428 Feb 2012 WO
2012036740 Mar 2012 WO
2012048035 Apr 2012 WO
2012127309 Sep 2012 WO
2012177942 Dec 2012 WO
2013021374 Feb 2013 WO
2013021375 Feb 2013 WO
2013021384 Feb 2013 WO
2013059747 Apr 2013 WO
2013072496 May 2013 WO
2013078497 Jun 2013 WO
2013114214 Aug 2013 WO
2013128436 Sep 2013 WO
2013175468 Nov 2013 WO
2014022124 Feb 2014 WO
2014076696 May 2014 WO
2014115149 Jul 2014 WO
2014121280 Aug 2014 WO
2014145338 Sep 2014 WO
2014144937 Sep 2014 WO
2014164364 Oct 2014 WO
2014194178 Dec 2014 WO
2015173794 Nov 2015 WO
2016016899 Feb 2016 WO
2016093877 Jun 2016 WO
2016125160 Aug 2016 WO
2016125160 Aug 2016 WO
2017223486 Dec 2017 WO
2018025260 Feb 2018 WO
2018025263 Feb 2018 WO
2018029680 Feb 2018 WO
2018039631 Mar 2018 WO
2018106837 Jun 2018 WO
2018108837 Jun 2018 WO
2018112429 Jun 2018 WO
2018118717 Jun 2018 WO
2018131042 Jul 2018 WO
2018131043 Jul 2018 WO
2019026059 Feb 2019 WO
2019030753 Feb 2019 WO
2019027507 Feb 2019 WO
2019077595 Apr 2019 WO
2019116369 Jun 2019 WO
2019138400 Jul 2019 WO
2019195860 Oct 2019 WO
2019202579 Oct 2019 WO
2020058972 Mar 2020 WO
2020167677 Aug 2020 WO
Non-Patent Literature Citations (253)
Entry
An International Preliminary Report on Patentability dated Oct. 20, 2020, which issued during the prosecution of Applicant's PCT/IL2019/050142.
An Office Action dated Oct. 5, 2020, which issued during the prosecution of Canadian Patent Application No. 2,973,940.
Notice of Allowance dated Nov. 19, 2020, which issued during the prosecution of U.S. Appl. No. 16/318,025.
An Office Action dated Sep. 24, 2020, which issued during the prosecution of U.S. Appl. No. 16/811,732.
An Office Action summarized English translation and Search Report dated Nov. 25, 2020, which issued during the prosecution of Chinese Patent Application No. 201910449820.1.
An Office Action dated Nov. 30, 2020, which issued during the prosecution of U.S. Appl. No. 16/138,129.
Poirier, Nancy C., et al. “A novel repair for patients with atrioventricular septal defect requiring reoperation for left atrioventricular valve regurgitation.” European journal of cardio-thoracic surgery 18.1 (2000): 54-61.
An Office Action dated Mar. 29, 2021, which issued during the prosecution of U.S. Appl. No. 16/738,516.
Ando, Tomo, et al. “Iatrogenic ventricular septal defect following transcatheter aortic valve replacement: a systematic review.” Heart, Lung and Circulation 25.10 (2016): 968-974.
Urena, Marina, et al. “Transseptal transcatheter mitral valve replacement using balloon-expandable transcatheter heart valves: a step-by-step approach.” JACC: Cardiovascular Interventions 10.19 (2017): 1905-1919.
An English summary of an Official Action dated Mar. 29, 2021, which issued during the prosecution of Chinese Patent Application No. 201780061210.3.
An International Search Report and a Written Opinion both dated Jan. 28, 2020, which issued during the prosecution of Applicant's PCT/IL2019/051031.
An International Preliminary Report on Patentability dated Mar. 9, 2021, which issued during the prosecution of Applicant's PCT/IL2019/051031.
An Office Action dated May 4, 2021, which issued during the prosecution of U.S. Appl. No. 16/636,204.
Notice of Allowance dated May 17, 2021, which issued during the prosecution of U.S. Appl. No. 16/138,129.
Notice of Allowance dated Jun. 4, 2021, which issued during the prosecution of U.S. Appl. No. 16/802,353.
An Office Action dated May 12, 2021, which issued during the prosecution of Canadian Patent Application No. 2,973,940.
Petition for Inter Partes Review of U.S. Pat. No. 10,702,385—dated Jun. 4, 2021.
Declaration of Ivan Vesely, Ph.D. In Support of Petition for Inter Partes Review of U.S. Pat. No. 10,702,385—dated Jun. 4, 2021.
An Office Action dated Dec. 24, 2020, which issued during the prosecution of U.S. Appl. No. 16/144,054.
An Office Action dated Feb. 2, 2021, which issued during the prosecution of U.S. Appl. No. 16/811,732.
An Office Action dated Jan. 13, 2021, which issued during the prosecution of European Patent Application No. 15751089.2.
Maisano, F., et al. “The edge-to-edge technique: a simplified method to correct mitral insufficiency.” European journal of cardio-thoracic surgery 13.3 (1998): 240-246.
Declaration of Dr. Ivan Vesely, Ph.D. In Support of Petition for Inter Partes Review of U.S. Pat. No. 10,226,341—dated Dec. 17, 2020.
Petition for Inter Partes Review of U.S. Pat. No. 10,226,341 and Exhibits 1001-1013—dated Dec. 29, 2020.
An Office Action together with an English summary dated Mar. 3, 2021, which issued during the prosecution of Chinese Patent Application No. 201780047391.4.
Fucci, C., et al. “Improved results with mitral valve repair using new surgical techniques.” European journal of cardio-thoracic surgery 9.11 (1995): 621-627.
U.S. Appl. No. 60/128,690, filed Apr. 9, 1999.
Declaration of Ivan Vesely, Ph.D., in Support of Petition for Inter Partesreview of U.S. Pat. No. 7,563,267—dated May 29, 2019.
Batista, Randas JV, et al. “Partial left ventriculectomy to treat end-stage heart disease.” the Annals of thoracic surgery 64.3 (1997): 634-638.
Beall Jr, Arthur C., et al. “Clinical experience with a dacron velour-covered teflon-disc mitral-valve prosthesis.” The Annals of thoracic surgery 5.5 (1968): 402-410.
Mitral Valve Academic Research Consortium. “Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 1: Clinical Trial Design Principles A Consensus Document from the Mitral Valve Academic Research Consortium.” Journal of the American College of Cardiology 66.3 (2015): 278-307.
Kalbacher, D., et al. “1000 MitraClip™ procedures: Lessons learnt from the largest single-centre experience worldwide.” (2019): 3137-3139.
U.S. Appl. No. 60/613,867, filed Sep. 27, 2004.
An Office Action dated Nov. 23, 2012, which issued during the prosecution of U.S. Appl. No. 13/033,852.
An Office Action dated Dec. 31, 2012, which issued during the prosecution of U.S. Appl. No. 13/044,694.
An Office Action dated Feb. 6, 2013, which issued during the prosecution of U.S. Appl. No. 13/412,814.
Langer F et al., “RING plus STRING: Papillary muscle repositioning as an adjunctive repair technique for ischemic mitral regurgitation,” J Thorac Cardiovasc Surg 133:247-9, Jan. 2007.
Langer F et al., “RING+STRING: Successful repair technique for ischemic mitral regurgitation with severe leaflet tethering,” Circulation 120[suppl 1]: S85-S91, Sep. 2009.
“Transcatheter Valve-in-Valve Implantation for Failed Bioprosthetic Heart Valves”, J Webb et al., Circulation. Apr. 2010; 121: 1848-1857.
Jansen, J., Willeke, S., Reul, H. and Rum, G. (1992), Detachable Shape-Memory Sewing Ring for Heart Valves. Artificial Organs, 16:294-297. 1992 (an abstract).
Alexander S. Geha, et al., Replacement of degenerated mitral and aortic bioprostheses without explanation Ann Thorac Surg. Jun. 2001; 72:1509-1514.
An International Search Report and a Written Opinion both dated Oct. 13, 2011 which issued during the prosecution of Applicant's PCT/IL11/00231.
An Office Action dated Jul. 1, 2016, which issued during the prosecution of U.S. Appl. No. 14/161,921.
An International Search Report and a Written Opinion both dated Dec. 5, 2011, which issued during the prosecution of Applicant's PCT/IL11/00582.
An Office Action dated May 29, 2012, which issued during the prosecution of U.S. Appl. No. 12/840,463.
U.S. Appl. No. 61/555,160, filed Nov. 3, 2011.
U.S. Appl. No. 61/525,281, filed Aug. 19, 2011.
U.S. Appl. No. 61/537,276, filed Sep. 21, 2011.
U.S. Appl. No. 61/515,372, filed Aug. 5, 2011.
U.S. Appl. No. 61/492,449, filed Jun. 2, 2011.
U.S. Appl. No. 61/588,892, filed Jan. 20, 2012.
An International Search Report and a Written Opinion both dated Feb. 6, 2013, which issued during the prosecution of Applicant's PCT/IL12/00292.
An International Search Report and a Written Opinion both dated Feb. 6, 2013, which issued during the prosecution of Applicant's PCT/IL12/00293.
An Office Action dated Nov. 28, 2012, which issued during the prosecution of U.S. Appl. No. 12/961,721.
An Office Action dated Feb. 15, 2013, which issued during the prosecution of U.S. Appl. No. 12/840,463.
An Office Action dated Feb. 10, 2014, which issued during the prosecution of U.S. Appl. No. 13/033,852.
An Office Action dated Sep. 19, 2014, which issued during the prosecution of U.S. Appl. No. 13/044,694.
An International Search Report and a Written Opinion both dated Sep. 4, 2014 which issued during the prosecution of Applicant's PCT/IL2014/050087.
Invitation to Pay Additional Fees dated Jun. 12, 2014 PCT/IL2014/050087.
An Office Action dated Jun. 17, 2014, which issued during the prosecution of U.S. Appl. No. 12/961,721.
An Office Action dated Jul. 3, 2014, which issued during the prosecution of U.S. Appl. No. 13/033,852.
An Office Action dated May 23, 2014, which issued during the prosecution of U.S. Appl. No. 13/412,814.
Dominique Himbert; Mitral Regurgitation and Stenosis from Bioprosthesis and Annuloplasty Failure: Transcatheter approaches and outcomes, 24 pages Oct. 28, 2013.
An International Search Report and a Written Opinion both dated Mar. 17, 2014 which issued during the prosecution of Applicant's PCT/IL2013/050937.
An International Preliminary Report on patentabilty dated Dec. 2, 2013, which issued during the prosecution of Applicant's PCT/IL11/00582.
An Office Action dated Sep. 12, 2013, which issued during the prosecution of U.S. Appl. No. 13/412,814.
An Office Action dated Aug. 2, 2013, which issued during the prosecution of U.S. Appl. No. 13/033,852.
An International Preliminary Report on patentabilty dated Sep. 11, 2012, which issued during the prosecution of Applicant's PCT/IL2011/000231.
An Office Action dated Jul. 2, 2014, which issued during the prosecution of U.S. Appl. No. 13/811,308.
An Office Action dated Jan. 20, 2016, which issued during the prosecution of U.S. Appl. No. 14/161,921.
An Office Action dated Jul. 23, 2013, which issued during the prosecution of U.S. Appl. No. 12/961,721.
An Office Action dated Jul. 18, 2013, which issued during the prosecution of U.S. Appl. No. 13/044,694.
An Office Action dated Nov. 8, 2013, which issued during the prosecution of U.S. Appl. No. 12/840,463.
An Office Action dated Jun. 4, 2014, which issued during the prosecution of U.S. Appl. No. 12/840,463.
An Office Action dated Aug. 13, 2012, which issued during the prosecution of U.S. Appl. No. 13/044,694.
An Office Action dated Jul. 2, 2012, which issued during the prosecution of U.S. Appl. No. 13/033,852.
An Office Action dated Feb. 3, 2014, which issued during the prosecution of U.S. Appl. No. 13/811,308.
An International Preliminary Report on patentabilty dated Feb. 11, 2014, which issued during the prosecution of Applicant's PCT/IL12/00292.
An International Preliminary Report on patentabilty dated Feb. 11, 2014, which issued during the prosecution of Applicant's PCT/IL12/00293.
A Notice of Allowance dated Aug. 15, 2014, which issued during the prosecution of U.S. Appl. No. 13/412,814.
An Office Action dated Aug. 14, 2012, which issued during the prosecution of U.S. Appl. No. 12/961,721.
U.S. Appl. No. 61/283,819, filed Dec. 8, 2009.
Notice of Allowance dated Apr. 8, 2016, which issued during the prosecution of U.S. Appl. No. 14/237,258.
U.S. Appl. No. 61/756,034, filed Jan. 24, 2013.
U.S. Appl. No. 61/756,049, filed Jan. 24, 2013.
An International Preliminary Report on Patentability dated Jan. 31, 2017, which issued during the prosecution of Applicant's PCT/IL2015/050792.
An Invitation to pay additional fees dated Mar. 14, 2019, which issued during the prosecution of Applicant's PCT/IL2018/051350.
Notice of Allowance dated Apr. 20, 2018, which issued during the prosecution of U.S. Appl. No. 15/878,206.
An Office Action dated Dec. 10, 2015, which issued during the prosecution of U.S. Appl. No. 14/237,258.
An International Preliminary Report on Patentability dated Jul. 28, 2015, which issued during the prosecution of Applicant's PCT/IL2014/050087.
An Office Action dated Nov. 27, 2015, which issued during the prosecution of U.S. Appl. No. 14/626,267.
An Office Action dated Jan. 21, 2016, which issued during the prosecution of U.S. Appl. No. 14/237,264.
An Office Action dated Jan. 30, 2015, which issued during the prosecution of UK Patent Application No. 1413474.6.
An International Search Report and a Written Opinion both dated May 30, 2016, which issued during the prosecution of Applicant's PCT/IL2016/050125.
An Office Action dated Sep. 26, 2016, which issued during the prosecution of U.S. Appl. No. 14/763,004.
An Office Action dated Jan. 18, 2017, which issued during the prosecution of U.S. Appl. No. 14/626,267.
An Office Action dated Feb. 7, 2017, which issued during the prosecution of U.S. Appl. No. 14/689,608.
An Office Action dated Feb. 8, 2017, which issued during the prosecution of UK Patent Application No. 1613219.3.
An Office Action together dated Feb. 10, 2017, which issued during the prosecution of European Patent Application No. 12821522.5.
An International Search Report and a Written Opinion both dated Oct. 27, 2015, which issued during the prosecution of Applicant's PCT/IL2015/050792.
European Search Report dated Feb. 18, 2015, which issued during the prosecution of Applicant's European App No. 12821522.5.
Saturn Project—a novel solution for transcatheter heart valve replacement specifically designed to address clinical therapeutic needs on mitral valve: Dec. 2016.
Righini presentation EuroPCR May 2015 (Saturn)—(downloaded from: https://www.pcronline.com/Cases-resourcesimages/Resources/Course-videos-slides/2015/Cardiovascularinnovation-pipeline-Mitral-and-tricuspid-valve-interventions).
An Advisory Action dated Apr. 2, 2018, which issued during the prosecution of U.S. Appl. No. 14/763,004.
An Office Action dated Jul. 26, 2018, which issued during the prosecution of U.S. Appl. No. 15/872,501.
An Office Action dated May 4, 2018, which issued during the prosecution of U.S. Appl. No. 15/872,501.
An Office Action dated Apr. 20, 2018, which issued during the prosecution of U.S. Appl. No. 15/886,517.
An Office Action dated Aug. 9, 2018, which issued during the prosecution of U.S. Appl. No. 15/899,858.
An Office Action dated Aug. 9, 2018, which issued during the prosecution of U.S. Appl. No. 15/902,403.
An Office Action dated Jun. 28, 2018, which issued during the prosecution of Design U.S. Appl. No. 29/635,658.
An Office Action dated Jun. 28, 2018, which issued during the prosecution of Design U.S. Appl. No. 29/635,661.
Georg Lutter, MD, et al; “Percutaneous Valve Replacement: Current State and Future Prospects”, The Annals of Thoracic Surgery ; vol. 78, pp. 2199-2206; Dec. 2004.
An Office Action dated Jun. 6, 2018, which issued during the prosecution of UK Patent Application No. 1720803.4.
An International Search Report and a Written Opinion both dated Jun. 20, 2018, which issued during the prosecution of Applicant's PCT/IL2018/050024.
An Office Action dated Jun. 18, 2018, which issued during the prosecution of UK Patent Application No. 1800399.6.
An Office Action dated Oct. 23, 2017, which issued during the prosecution of U.S. Appl. No. 14/763,004.
An Office Action dated Dec. 7, 2017, which issued during the prosecution of U.S. Appl. No. 15/213,791.
Interview Summary dated Feb. 8, 2018, which issued during the prosecution of U.S. Appl. No. 15/213,791.
An Office Action dated Feb. 7, 2018, which issued during the prosecution of U.S. Appl. No. 15/197,069.
An Office Action dated Jun. 15, 2018, which issued during the prosecution of U.S. Appl. No. 15/970,314.
An Office Action dated Jan. 5, 2018, which issued during the prosecution of U.S. Appl. No. 15/541,783.
An Office Action dated Feb. 2, 2018, which issued during the prosecution of U.S. Appl. No. 15/329,920.
An Invitation to pay additional fees dated Jan. 2, 2018, which issued during the prosecution of Applicant's PCT/IL2017/050849.
An Invitation to pay additional fees dated Sep. 29, 2017, which issued during the prosecution of Applicant's PCT/IL2017/050873.
European Search Report dated Jun. 29, 2017, which issued during the prosecution of Applicant's European App No. 11809374.9.
An Invitation to pay additional fees dated Oct. 11, 2018, which issued during the prosecution of Applicant's PCT/IL2018/050725.
An Office Action dated Dec. 4, 2018, which issued during the prosecution of U.S. Appl. No. 16/045,059.
An Office Action together with the English translation dated Nov. 5, 2018 which issued during the prosecution of Chinese Patent Application No. 201680008328.5.
Notice of Allowance dated Sep. 25, 2018, which issued during the prosecution of U.S. Appl. No. 15/188,507.
European Search Report dated Sep. 26, 2018 which issued during the prosecution of Applicant's European App No. 18186784.7.
An Office Action dated Jun. 30, 2015, which issued during the prosecution of U.S. Appl. No. 14/522,987.
Notice of Allowance dated Dec. 13, 2013, which issued during the prosecution of U.S. Appl. No. 13/675,119.
An International Preliminary Report on Patentability dated Aug. 8, 2017, which issued during the prosecution of Applicant's PCT/IL2016/050125.
An Office Action dated Jan. 17, 2018, which issued during the prosecution of U.S. Appl. No. 14/763,004.
An Office Action dated Mar. 25, 2015, which issued during the prosecution of U.S. Appl. No. 12/840,463.
An Office Action dated Feb. 25, 2016, which issued during the prosecution of U.S. Appl. No. 14/522,987.
An Office Action dated Apr. 13, 2016, which issued during the prosecution of U.S. Appl. No. 14/626,267.
An Office Action dated Aug. 28, 2015, which issued during the prosecution of U.S. Appl. No. 14/237,264.
Maisano (2015) TCR presentation re Cardiovalve.
Notice of Allowance dated Sep. 29, 2016, which issued during the prosecution of U.S. Appl. No. 14/442,541.
Notice of Allowance dated May 10, 2016, which issued during the prosecution of U.S. Appl. No. 14/237,258.
Notice of Allowance dated May 20, 2016, which issued during the prosecution of U.S. Appl. No. 14/237,258.
An International Preliminary Report on Patentability dated May 19, 2015, which issued during the prosecution of Applicant's PCT/IL2013/050937.
Dusan Pavcnik, MD, PhD2, et al; “Development and Initial Experimental Evaluation of a Prosthetic Aortic Valve for Transcatheter Placement”, Cardiovascular Radiology. Radiology Apr. 1992, vol. 183, pp. 151-154.
Notice of Allowance dated Oct. 16, 2013, which issued during the prosecution of U.S. Appl. No. 13/675,119.
Notice of Allowance dated Feb. 11, 2015, which issued during the prosecution of U.S. Appl. No. 13/033,852.
Notice of Allowance dated May 5, 2015, which issued during the prosecution of U.S. Appl. No. 12/840,463.
Notice of Allowance dated Mar. 10, 2015, which issued during the prosecution of U.S. Appl. No. 13/811,308.
Notice of Allowance dated Jul. 1, 2016, which issued during the prosecution of U.S. Appl. No. 14/442,541.
An Office Action dated Mar. 25, 2019, which issued during the prosecution of European Patent Application No. 14710060.6.
An International Search Report and a Written Opinion both dated Nov. 9, 2018, which issued during the prosecution of Applicant's PCT/IL2018/050869.
An International Search Report and a Written Opinion both dated Dec. 5, 2018, which issued during the prosecution of Applicant's PCT/IL2018/050725.
An International Search Report and a Written Opinion both dated Apr. 25, 2019, which issued during the prosecution of Applicant's PCT/IL2019/050142.
An International Preliminary Report on Patentability dated Feb. 12, 2019, which issued during the prosecution of Applicant's PCT/IL2017/050873.
An Office Action dated Sep. 13, 2019, which issued during the prosecution of U.S. Appl. No. 16/460,313.
An Office Action dated Nov. 26, 2019, which issued during the prosecution of U.S. Appl. No. 16/532,945.
An Office Action dated Aug. 16, 2019, which issued during the prosecution of U.S. Appl. No. 15/668,659.
An Office Action dated Nov. 1, 2019, which issued during the prosecution of U.S. Appl. No. 15/872,501.
An Office Action dated Jun. 14, 2019, which issued during the prosecution of U.S. Appl. No. 15/703,385.
An Office Action dated Oct. 4, 2019, which issued during the prosecution of U.S. Appl. No. 16/183,140.
An Office Action dated Jun. 13, 2019, which issued during the prosecution of U.S. Appl. No. 16/388,038.
An International Search Report and a Written Opinion both dated Jan. 25, 2019, which issued during the prosecution of Applicant's PCT/IL2018/051122.
An Office Action dated Oct. 25, 2018, which issued during the prosecution of U.S. Appl. No. 14/763,004.
An International Search Report and a Written Opinion both dated May 13, 2019, which issued during the prosecution of Applicant's PCT/IL2018/051350.
An International Preliminary Report on Patentability dated Feb. 5, 2019, which issued during the prosecution of Applicant's PCT/IL2017/050849.
Notice of Allowance dated Jan. 13, 2020, which issued during the prosecution of U.S. Appl. No. 15/956,956.
An Office Action dated Mar. 4, 2019, which issued during the prosecution of U.S. Appl. No. 14/763,004.
An Office Action dated Jan. 9, 2019, which issued during the prosecution of U.S. Appl. No. 15/329,920.
An Office Action dated Jan. 30, 2019, which issued during the prosecution of U.S. Appl. No. 15/872,501.
An Office Action dated Feb. 5, 2019, which issued during the prosecution of U.S. Appl. No. 15/899,858.
An Office Action dated May 23, 2019, which issued during the prosecution of U.S. Appl. No. 15/668,659.
An Office Action dated May 1, 2019, which issued during the prosecution of U.S. Appl. No. 15/691,032.
An Office Action dated Aug. 1, 2019, which issued during the prosecution of U.S. Appl. No. 15/668,559.
An Office Action dated Jun. 19, 2019, which issued during the prosecution of U.S. Appl. No. 15/682,789.
An Office Action dated Jun. 25, 2019, which issued during the prosecution of U.S. Appl. No. 15/329,920.
An Office Action dated May 16, 2019, which issued during the prosecution of U.S. Appl. No. 15/433,547.
U.S. Appl. No. 62/112,343, filed Feb. 5, 2015.
An Office Action dated Nov. 16, 2018, which issued during the prosecution of U.S. Appl. No. 16/042,028.
An Office Action dated May 8, 2018, which issued during the prosecution of U.S. Appl. No. 15/902,403.
Tchetche, D. and Nicolas M. Van Mieghem: New-generation TAVI devices: description and specifications/EuroIntervention, 2014, No. 10:U90-U100.
An Office Action dated Jan. 6, 2020, which issued during the prosecution of U.S. Appl. No. 16/660,231.
An Advisory Action dated Jan. 2, 2020, which issued during the prosecution of U.S. Appl. No. 15/668,659.
Notice of Allowance dated Jul. 19, 2019, which issued during the prosecution of U.S. Appl. No. 15/899,858.
An Office Action dated Nov. 23, 2018, which issued during the prosecution of U.S. Appl. No. 16/041,208.
An Office Action dated Jul. 11, 2018, which issued during the prosecution of U.S. Appl. No. 15/978,494.
Symetis S.A.: “ACURATE neo™ Aortic Bioprosthesis for Implantation using the ACURATE neo™ TA Transapical Delivery System in Patients with Severe Aortic Stenosis,” Clinical Investigation Plan, Protocol No. 2015-01, Vs. No. 2, 2015:1-76:
An Office Action dated Nov. 26, 2018, which issued during the prosecution of U.S. Appl. No. 16/040,831.
An Office Action dated Dec. 31, 2019, which issued during the prosecution of U.S. Appl. No. 16/183,140.
An Office Action dated Jan. 14, 2020, which issued during the prosecution of U.S. Appl. No. 16/284,331.
European Search Report dated Mar. 5, 2020 which issued during the prosecution of Applicant's European App No. 17752184.6.
European Search Report dated Mar. 4, 2020 which issued during the prosecution of Applicant's European App No. 16706913.7.
Notice of Allowance dated Mar. 12, 2020, which issued during the prosecution of U.S. Appl. No. 16/460,313.
An Office Action dated Jan. 9, 2020, which issued during the prosecution of U.S. Appl. No. 15/600,190.
An Office Action dated Jan. 3, 2020, which issued during the prosecution of U.S. Appl. No. 16/678,355.
An Office Action dated Feb. 6, 2020, which issued during the prosecution of U.S. Appl. No. 15/668,659.
An Office Action dated Sep. 6, 2018, which issued during the prosecution of U.S. Appl. No. 15/994,022.
An Office Action dated Sep. 7, 2018, which issued during the prosecution of U.S. Appl. No. 15/995,725.
An International Search Report and Written Opinion both dated Mar. 27, 2018, which issued during the prosecution of Applicant's PCT/IL2017/050849.
Notice of Allowance dated Oct. 5, 2018, which issued during the prosecution of U.S. Appl. No. 15/886,517.
An Office Action dated Oct. 12, 2018, which issued during the prosecution of U.S. Appl. No. 15/970,314.
An Office Action dated May 11, 2018, which issued during the prosecution of U.S. Appl. No. 15/899,858.
An Office Action dated Jul. 26, 2018, which issued during the prosecution of U.S. Appl. No. 15/979,686.
An Office Action dated Sep. 10, 2018, which issued during the prosecution of U.S. Appl. No. 16/008,618.
Sündermann, Simon H., et al. “Feasibility of the Engager™ aortic transcatheter valve system using a flexible over-the-wire design.” European Journal of Cardio-Thoracic Surgery 42.4 (2012): e48-e52.
Serruys, P. W., Piazza, N., Cribier, A., Webb, J., Laborde, J. C., & de Jaegere, P. (Eds.). (2009). Transcatheter aortic valve implantation: tips and tricks to avoid failure. CRC Press.—Screenshots from Google Books downloaded from: https://books.google.co.il/books?id=FLzLBQAAQBAJ&1pg=PA198&ots=soqWrDH-y_&dq=%20%22Edwards%20SAPIEN%22&lr&pg=PA20#v=onepage&q=%22Edwards%20SAPIEN%22&f=false ; Downloaded on Jun. 18, 2020.
Notice of Allowance dated May 7, 2020, which issued during the prosecution of U.S. Appl. No. 16/637,166.
Notice of Allowance dated Sep. 10, 2020, which issued during the prosecution of U.S. Appl. No. 15/600,190.
Notice of Allowance dated Jul. 29, 2020, which issued during the prosecution of U.S. Appl. No. 16/132,937.
An Office Action dated Aug. 7, 2020, which issued during the prosecution of U.S. Appl. No. 15/668,659.
An International Search Report and a Written Opinion both dated Jun. 24, 2020, which issued during the prosecution of Applicant's PCT/IL2019/051398.
An Office Action dated Jul. 29, 2020, which issued during the prosecution of U.S. Appl. No. 16/269,328.
Notice of Allowance dated Aug. 26, 2020, which issued during the prosecution of U.S. Appl. No. 16/269,328.
An Office Action dated Jul. 14, 2020, which issued during the prosecution of U.S. Appl. No. 16/324,339.
Notice of Allowance dated Aug. 28, 2020, which issued during the prosecution of U.S. Appl. No. 16/324,339.
An Office Action summarized English translation and Search Report dated Jul. 3, 2020, which issued during the prosecution of Chinese Patent Application No. 201780061210.3.
Petitioners' Opposition to Patent Owner's Contingent Motion to Amend, Filed Jan. 5, 2022, Edwards Lifesciences Corporation and Edwards Lifesciences LLC v. Cardiovalve Ltd., IPR2021-00383, 32 pages.
Petitioners' Reply to Patent Owner's Reponse, Filed Jan. 5, 2022, Edwards Lifesciences Corporation and Edwards Lifesciences LLC v. Cardiovalve Ltd., IPR2021-00383, 41 pages.
Notice of Allowance dated Dec. 6, 2021, issued for U.S. Appl. No. 16/738,516, 30 pages.
Notice of Allowance dated Dec. 29, 2021, issued for U.S. Appl. No. 17/210,183, 13 pages.
Notice of Allowance dated Dec. 7, 2021, issued for U.S. Appl. No. 17/394,807, 115 pages.
Non-Final Office Action dated Jan. 12, 2022, issued for U.S. Appl. No. 17/101,787, 17 pages.
European Patent Office Communication pursuant to Rule 164(2)(b) and Article 94(3) EPC for App. No. EP18826823.9, dated Nov. 25, 2021, 14 pages.
European Patent Office Communication pursuant to Article 94(3) EPC for App. No. EP20714289.4, dated Sep. 22, 2021, 5 pages.
Decision Granting Institution of Inter Partes Review 35 USC §314, dated Dec. 10, 2021, Edwards Lifesciences Corporation and Edwards Lifesciences LLC v. Cardiovalve Ltd., IPR2021-00383, 42 pages.
English translation of Chinese Office Action issued for CN201880064313.X, dated Jan. 6, 2022, 3 pages.
An Office Action dated Sep. 15, 2021, which issued during the prosecution of U.S. Appl. No. 16/135,599.
Notice of Allowance dated Oct. 14, 2021, which issued during the prosecution of U.S. Appl. No. 16/680,739.
An Office Action dated Oct. 21, 2021, which issued during the prosecution of U.S. Appl. No. 17/335,845.
European Search Report dated Oct. 11, 2021 which issued during the prosecution of Applicant's European App No. 21176010.3.
Fann, James I., et al. “Beating heart catheter-based edge-to-edge mitral valve procedure in a porcine model: efficacy and healing response.” Circulation 110.8 (2004): 988-993.
Feldman, Ted, et al. “Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort.” Journal of the American College of Cardiology 54.8 (2009): 686-694.
IPR2021-00383 Patent Owner's Contingent Motion to Amend Under 37 C.F.R. 42.121 dated Oct. 13, 2021.
IPR2021-00383 Patent Owner's Response Pursuant to 37 C.F.R. 42.120 dated Oct. 13, 2021.
IPR2021-00383 Second Declaration of Dr. Michael Sacks dated Oct. 13, 2021.
An Office Action dated Oct. 21, 2021, which issued during the prosecution of U.S. Appl. No. 17/306,231.
Maisano, Francesco, et al. “The evolution from surgery to percutaneous mitral valve interventions: the role of the edge-to-edge technique.” Journal of the American College of Cardiology 58.21 (2011): 2174-2182.
IPR2021-00383 Deposition of Dr. Ivan Vesely, dated Sep. 22, 2021.
Cardiovalve Exhibit 2009—Percutaneous Mitral Leaflet Repair: MitraClip® Therapy for Mitral Regurgitation (2012).
Feldman, Ted, et al. “Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial.” Journal of the American College of Cardiology 46.11 (2005): 2134-2140.
An Office Action summarized English translation and Search Report dated Oct. 8, 2021, which issued during the prosecution of Chinese Patent Application No. 201780061210.3.
An Office Action dated Nov. 4, 2021, which issued during the prosecution of U.S. Appl. No. 17/366,711.
An Office Action summarized English translation and Search Report dated Aug. 12, 2021, which issued during the prosecution of Chinese Patent Application No. 201880058940.2.
European Search Report dated Jun. 10, 2021 which issued during the prosecution of Applicant's European App No. 21157988.3.
An Invitation to pay additional fees dated May 19, 2021, which issued during the prosecution of Applicant's PCT/IL2021/050132.
An International Search Report and a Written Opinion both dated Jul. 12, 2021, which issued during the prosecution of Applicant's PCT/IL2021/050132.
IPR2021-00383 Petitioners' Authorized Reply to Patent Owner's Preliminary Response dated May 27, 2021.
Exhibit 1014—Transcript of proceedings held May 20, 2021 (Edwards Lifesciences vs. Cardiovalve).
Exhibit 1015—Facilitate, Meriam-Webster.com, https://www.merriamwebster.com/dictionary/facilitate (visited May 26, 2021).
Patent Owner's Authorized Surreply to Petitioner's Reply to Patent Owner's Preliminary Response dated Jun. 4, 2021 (Edwards Lifesciences vs. Cardiovalve).
An Office Action dated Aug. 18, 2021, which issued during the prosecution of U.S. Appl. No. 17/210,183.
Institution decision dated Jul. 20, 2021 (Edwards Lifesciences vs. Cardiovalve).
International Search Report and Written Opinion issued in App. No. PCT/IL2021/051433, dated May 3, 2022, 26 pages.
Related Publications (1)
Number Date Country
20210322167 A1 Oct 2021 US